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Pancreatic adenocarcinoma is a leading cause of cancer death with a five-year survival 
rate of only 5%. Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA), the 
current diagnostic standard, cannot reliably rule out malignancy and is insensitive to 
distinguishing adenocarcinoma from chronic pancreatitis (inflammation). To investigate 
the ability of multi-modal optical spectroscopy to detect signals from human pancreatic 
tissue, a clinically-compatible instrument was developed for rapid, quantitative 
reflectance and fluorescence spectroscopy in tissues, including fluorescence lifetime 
sensing. Reflectance and fluorescence spectra and time-resolved fluorescence decay 
curves were successfully measured for the first time from freshly excised human 
pancreatic tissues and in vivo human pancreatic cancer xenografts in mice. 
For the first time, pancreatic tissue classification algorithms using optical spectroscopy 
data were developed. A total of 96 fluorescence and 96 reflectance spectra were 
considered from 50 sites (adenocarcinoma, chronic pancreatitis, and normal tissues) on 9 
patients. The SpARC (Spectral Areas and Ratios Classifier) and PCA (principal 
component analysis) algorithms employed linear discriminant analysis on classification 
variables extracted from optical data. Maximum sensitivity, specificity, NPV, and PPV 
(85%, 89%, 92%, and 80%, respectively for the SpARC, and 91%, 90%, 95%, 83%, 
respectively for the PCA algorithm) for correctly identifying adenocarcinoma were 
achieved employing both reflectance and fluorescence spectra. Inclusion of time-resolved 
fluorescence data in the PCA algorithm further improved the distinction between 
 xvi
pancreatitis and normal tissues in a limited data set. Importantly, the sensitivity of both 
algorithms far exceeds reported EUS-FNA sensitivity (54%) at distinguishing 
adenocarcinoma from chronic pancreatitis. The developed algorithms show promise for 
rapid automated pancreatic tissue classification using multi-modal optical spectroscopy 
and could be employed in a clinical setting. 
The possibility of applying optical spectroscopy to evaluate tissue engineered devices 
was also investigated. Tissue engineered constructs are functional biologic devices 
employed for grafting wounds or replacing diseased tissue. Non-invasive methods are 
required to assess the viability of these engineered constructs. Monte Carlo simulations 
and multi-modal optical spectroscopy were coupled to assess porcine articular cartilage 
and oral mucosa constructs for the first time. The developed methods would be safe for 







Chapter 1                                                                
Introduction 
1.1  Optical spectroscopy for biological sensing 
The interaction of light with complex, inhomogeneous media such as biological tissue is 
characterized by a variety of processes that depend on the physical nature of the light and 
the specific morphology and composition of the tissue [1, 2]. Incident light may be 
scattered (elastically or inelastically) multiple times due to microscopic differences in the 
index of refraction within the tissue, it may be absorbed by fluorophores (e.g. cellular 
NAD(P)H or FAD and extracellular collagen), which may then release their excess 
energy by radiative decay, producing fluorescence or be non-radiatively absorbed by 
chromophores present in the medium [3-5]. The remitted fluorescent light may, in turn, 
be multiply scattered or absorbed. The, reflected and fluorescent light reaching the tissue 
surface is affected by scattering (e.g., from inhomogeneities including extracellular 
matrix and membranes and intracellular nuclei and mitochondria) and absorption (e.g., 
from hemoglobin and proteins) properties of the tissue.  
Methods of optical spectroscopy and imaging are being developed for a variety of 
biomedical applications in non- or minimally-invasive tissue diagnostics, including 
sensing molecular concentrations of delivered pharmaceutical or contrast agents, probing 
tissue physiologic status, and detecting early stages of disease in vitro and in vivo [2-10]. 
The work in this dissertation applies reflectance and fluorescence spectroscopy for the 
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assessment of biological tissues without the use of contrast agents. The remaining text of 
this chapter introduces these modalities of optical spectroscopy, motivates the optical 
assessment of biological tissue studied in this dissertation, lists the specific aims of the 
dissertation, and concludes with an outline for the remaining thesis. 
Spectral (steady-state) detection of fluorescence emission resolves the variation of 
fluorescence intensity with wavelength of emitted light [11]. Endogenous tissue 
fluorescence non-invasively provides information about the native biochemical 
composition and microenvironment in living tissues without the use of exogenous 
contrast agents [8-10]. Endogenous fluorescence spectra recorded from biological 
systems like cells and tissues are composed of spectral bands from multiple constituent 
fluorophores, including extracellular structural proteins (such as collagen and elastin) and 
intracellular metabolic co-factors (NAD(P)H and FAD) [9]. Fluorescence intensities are 
sensitive to factors including variations in excitation intensity, fluorophore concentration, 
photobleaching, and sources of optical loss (absorption and scattering) in biological 
systems [11, 12]. To gain diagnostic value, these complex spectra are analyzed 
chemometrically or modeled computationally [4, 7, 13-23]. 
Time-resolved fluorescence techniques capture the transient decay of the fluorescence 
intensity in time. This decay reflects the relative concentrations and the excited-state 
lifetimes of the endogenous fluorophores contributing to the emission [11].  Fluorophore 
lifetimes are sensitive to the local biochemical environment and vary with pH and 
oxygenation [11]. However, time-resolved measurements do not vary with fluorescence 
intensity because they are generally independent of artifacts influencing fluorescence 
steady-state measurements. This is important when applying fluorescence spectroscopy in 
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vivo, since intensity losses seen in the steady-state emission spectrum due to absorption 
of light by hemoglobin in tissue would not affect time-resolved measurements [24, 25]. 
Reflectance spectroscopy relies upon the absorption and elastic scattering of light in 
tissues, which depend on tissue composition (e.g., oxy- vs. deoxy-hemoglobin content) 
and index of refraction variations (e.g., cell nuclei size, shape, and density), respectively.  
Reflectance methods have been employed to distinguish neoplastic from normal 
epithelial tissues in the colon [26] and in studies of Barrett’s esophagus [27], as well as to 
characterize tissues in solid organs, such as the breast [28].   
These different measurement modalities (steady-state fluorescence, time-resolved 
fluorescence, and reflectance spectroscopy) can thus provide complimentary information 
about biological tissue. For example, studies in the breast, which is a solid organ like the 
pancreas, have demonstrated improved diagnostic discrimination of inflammatory and 
malignant breast tissues ex vivo via the use of a multi-modal approach involving both 
fluorescence and reflectance studies [21].   
In this dissertation work, instrumentation for reflectance and fluorescence spectroscopy, 
including lifetime sensing, was developed and applied to non-invasively study natural 
pancreatic tissues, porcine articular cartilage, and engineered oral mucosa.    
1.2  Motivation 
1.2.1 Pancreatic Adenocarcinoma 
 
Pancreatic adenocarcinoma has a five-year survival rate of only 5%, making it the fourth-
leading cause of cancer death in the United States [29]. Current diagnostic procedures are 
unable to diagnose the disease in its early stages [30]. In various imaging modalities, 
 4
diagnosis is compromised due to similarities in the appearance of chronic pancreatitis 
(inflammation of the pancreas) and adenocarcinoma [30]. Endoscopic ultrasound-guided 
fine needle aspiration (EUS-FNA) is the current clinical standard for the diagnosis of 
pancreatic adenocarcinoma. In EUS-FNA, ultrasound is employed to guide a hollow 
needle through an endoscope into the suspected pancreatic mass. Cells from the 
suspected mass are sampled via the needle and analyzed by a cytopathologist for 
malignancy. Small specimen size, overlap with chronic pancreatitis in the diagnostic 
features seen at cytological evaluation, and EUS-FNA operator dependence make this 
technique inconsistent in its performance at detecting pancreatic cancer. This is apparent 
from the wide range of sensitivities (54 – 95%), specificities (71- 100%), and negative 
predictive values (NPVs) (16-92%) of adenocarcinoma detection reported for this method 
(Figure 1.1a) in a recent meta-analysis of 28 EUS-FNA studies [30]. In particular, EUS-
FNA has only 54% sensitivity (Figure 1.1b) for adenocarcinoma in the setting of chronic 
pancreatitis (i.e. when the patient has both adenocarcinoma and chronic pancreatitis) [31] 
and the two conditions frequently coexist. The exceedingly large range (16-92%), and 
low median (72%) of the NPV indicated the inability of EUS-FNA to definitively rule-
out malignancy, thus leading to the conclusion that “preoperative biopsy of potentially 
resectable pancreatic tumors is not generally advisable, as malignancy cannot be ruled 
out with adequate reliability” [30]. A study found that as many as 9% of patients undergo 
complicated pancreatic surgery, only to reveal absence of malignancy during pathological 
examination of the resected specimen [32]. Clearly, detection of pancreatic 
adenocarcinoma in its early stages and its distinction from chronic pancreatitis could 
greatly improve the chances of patient survival.  
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Multiple studies have employed optical techniques for minimally invasive detection of 
breast, cervical, colon, and esophageal cancers, including [3, 4, 27, 33-36].   
 
Figure 1.1 The median and range of sensitivity, specificity, NPV, and PPV for adenocarcinoma 
identification reported in a meta-analysis of 28 EUS-FNA studies [30]. (b) The performance of 
EUS-FNA for distinguishing between adenocarcinoma and chronic pancreatitis in the setting of 
chronic pancreatitis as reported in a study [31]. 
   
However, owing to the relative inaccessibility of the pancreas, only a handful of studies 
have applied optical methods for pancreatic cancer detection. Optical coherence 
tomography was applied to both in vivo and ex vivo detection of pancreatic cancer [37, 
38] and near-infrared spectroscopy [39] was applied ex vivo. Pancreatic cancer cells on 
microscope slides were studied employing partial-wave microscopic spectroscopy [40]. A 
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in the pancreas [41, 42] was studied ex vivo using four-dimensional elastic light-
scattering, and low-coherence enhanced backscattering spectroscopies.  
The aim of the study reported here was to employ reflectance and fluorescence 
spectroscopy for differentiating between pancreatic adenocarcinoma, chronic pancreatitis, 
and normal pancreatic tissue. Tissue classification algorithms were developed to classify 
the measured optical spectroscopy data employing linear discriminant analysis and 
principal component analysis. 
1.2.2 Non-invasive sensing of tissue engineered constructs 
Tissue engineering is the process of creating functional biologic devices either for 
grafting wounds or for replacing diseased tissues. A significant challenge in tissue 
engineering is the non-invasive, quantitative assessment of the viability of these 
engineered tissue constructs, and how they compare to normal biologic tissue. At present, 
evaluation of soft tissue regeneration of engineered tissue constructs during the 
manufacturing process or post-implantation into patients is done mostly via histology. 
First, this approach is invasive and requires time-consuming sectioning of the tissue for 
staining to be performed. Second, histology is inherently qualitative since the stain color 
and intensity may not reflect the amount of matrix present in the soft tissue. Biochemical 
assays can also be employed to measure, for example, the level of glucose uptake from 
the cell culture media in which the tissue constructs are being grown [43]. While such a 
method could be non-invasive, quantitative, and able to assess overall cell viability, it 
cannot provide spatial information about the functionality of the construct. In addition, 
such a technique could not be employed post-implantation into patients. 
 
 7
Table 1.1. Methods to assess the viability of tissue engineered constructs 
Histology Biochemical Assays Optical Methods 
Destructive Non-invasive Non-invasive 
Qualitative/ Subjective Quantitative/ Objective Quantitative/ Objective 
Labor intensive Real-time monitoring Real-time monitoring 
No spatial information No spatial information Spatial information 
Invasive monitoring post-





endogenous contrast  
  
An optical spectroscopy or optical imaging technique could non-invasively and 
quantitatively determine soft tissue composition or cellular function and would represent 
a significant advance in the assessment of engineered tissues. Since the method would be 
non-destructive, it would allow repeated assessment of a given sample over time, thereby 
significantly speeding up lengthy and expensive protocols requiring multiple samples. 
Furthermore, the method could provide spatial information about the biological viability 
of the construct via fiber optic probes both pre- and post- implantation into patients.  
Table 1.1 compares the present methods for assessing viability of tissue engineered 
constructs with the proposed optical methods. 
In order to quantify optical measurements made in biological tissues, it is necessary to be 
able to describe accurately all light-tissue interactions (composed of elastic scattering of 
both incident and remitted light, as well as absorption of incident excitation by tissue 
chromophores or fluorophores). A widely used technique for quantitative simulations of 
light-tissue interactions involves the use of Monte Carlo (MC) models for photon 
transport in turbid media; an approach proven to provide accurate predictions of light 
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energy distribution in turbid media along with the ability to model complex tissue 
architectures and source-detector geometries [10, 44]. 
In this dissertation, reflectance and fluorescence spectroscopy and previously developed 
MC simulations were coupled towards the goal of assessing viability of two tissue 
engineered constructs namely, articular cartilage constructs, and oral mucosa constructs. 
A significant advantage of the methods employed in this work was the use of endogenous 
contrast for non-invasive quantitative assessment, thus ensuring safety for clinical human 
use.  
1.2.2.1 Articular cartilage constructs  
Hyaline articular cartilage (AC) is found in the synovial joints and is an important 
contributor to the functional capacities of these joints [45]. If a chondral defect or lesion 
occurs, it does not heal on its own. Thus methods are being developed to make tissue 
constructs that would mimic true AC. Pre- and post implantation non-invasive viability 
testing of these constructs can potentially be done by analyzing their optical signals. 
Here, we present a novel combination of experiment and computation to quantitatively 
characterize fresh porcine knee cartilage using endogenous fluorescence. Fluorescence 
data and simulations were used to extract a quantitative measure to monitor relative 
changes in concentration of the constituent fluorophores in AC tissue over time. The 
porcine articular cartilage (AC) tissue samples studied offered the biological variability 
not found in artificial tissue-simulating phantoms and will serve as a model for future 
optical molecular sensing studies on tissue engineered AC constructs intended for use in 
human therapy. 
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1.2.2.2 Ex Vivo Produced Oral Mucosa Equivalent (EVPOME) 
constructs 
Oral surgeries or trauma in humans can result in open wounds that are susceptible to 
infections and require grafting by either skin or oral mucosa grafts from donor sites [43, 
46]. The procedure however involves multiple surgeries and can result in donor site 
morbidity. In addition, non-oral mucosa grafts, such as skin, have different keratinization 
patterns. Tissue engineered ex vivo produced oral mucosa equivalent (EVPOME) 
constructs can be used to graft oral wounds. To manufacture these constructs, oral 
keratinocytes from the patient are suspended in an artificial, biologically compatible 
matrix at day 0 and the cell-matrix composite is grown to form the tissue construct, ready 
for implantation at day 11. Since the cells are obtained from the patient’s own mouth, 
there is no risk of rejection by the patient’s immune system or a difference in 
keratinization pattern. The EVPOME has been successfully tested in a Phase I human 
clinical trial. 
Quantitative, non-invasive tools are required to monitor structure, composition, and 
function of these engineered tissues in real time. Non-invasive tools can be developed to 
assist in creating release criteria for the manufactured engineered tissues, in vitro, and for 
assessing tissue performance after their grafting, in situ. 
In this dissertation work, non-invasive optical assessment of cell viability in EVPOME 
constructs by employing fluorescence spectroscopy via fiber optic probes was 
investigated. Measuring the fluorescence from the same healthy EVPOME construct 
under sterile conditions from day 0 to day 11 could be used for characterizing the 
fluorescence expected from a viable construct from day 0 to day 11. This information 
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could then be used to discard faulty constructs early on in the manufacturing process, 
thereby saving time and resources. 
The use of a non-invasive quantitative optical technique could establish a release criteria 
of an engineered tissue in a more comprehensive fashion, i.e., viability, structure and 
metabolic activity, compared with presently used assay systems, such as glucose uptake. 
The development of release criteria in real time will improve the quality control of 
engineered tissues during their manufacturing process. The technique, once developed, 
will also allow the ability to assess tissue viability in situ, non-invasively, after grafting 
into animals and, eventually, into humans.   
1.3  Dissertation objectives 
Specific Aim 1: To design and develop instrumentation for reflectance and 
fluorescence spectroscopy. A clinically compatible instrument for rapid, quantitative 
optical sensing in biological tissues using reflectance and fluorescence spectroscopy, 
including fluorescence lifetime sensing will be developed.  
 
Specific Aim 2: To assess the application of fluorescence and reflectance 
spectroscopy for differentiating between human pancreatic adenocarcinoma, 
chronic pancreatitis (inflammation of the pancreas), and normal pancreatic tissues. 
The developed clinical instrumentation will be employed, for the first time, to perform 
reflectance and fluorescence spectroscopies on human pancreatic xenografts in mice and 
from human pancreatic tissues. Chemometric tissue classification algorithms that employ 
principal component analysis (PCA) and linear discriminant analysis (LDA) will be 
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developed for the first time for pancreatic tissue classification using optical spectroscopy 
data.  
 
Specific Aim 3: To assess the application of optical spectroscopy for non-invasive 
assessment of tissue engineered constructs. The developed clinical instrumentation and 
previously developed Monte Carlo (MC) codes of photon transport in turbid media will 
be employed for the first time to optically characterize porcine articular cartilage and ex 
vivo produced oral mucosa constructs (EVPOME) in a non-invasive and quantitative 
manner.  
1.4  Dissertation overview 
The dissertation has been organized as follows: 
Chapter 2 introduces the theoretical concepts of fluorescence and reflectance 
spectroscopy and introduces Monte Carlo modeling of photon transport in turbid media. 
Chapter 3 describes in detail the developed clinical instrumentation for reflectance and 
fluorescence spectroscopy, including lifetime sensing. The chapter includes the optical 
and electrical design of the instrument and describes the software developed for 
controlling the instrument. The chapter also describes the instrument calibration and data 
processing required after data acquisition.  
Chapter 4 describes the application of the developed technology to the first in vivo 
measurements of fluorescence and reflectance spectra from human pancreatic cancer 
xenografts in NOD/SCID mice (non-obese diabetic/severe combined immunodeficiency). 
It also describes the first ex vivo measurements of fluorescence and reflectance spectra 
and fluorescence life-time decays from freshly excised human pancreatic tissue. A 
 12
correlation of the optical measurements with known histological features of normal, 
pancreatitis, and adenocarcinoma pancreatic tissues is described. 
Chapter 5 describes the development of the first pancreatic tissue classification 
algorithms employing the measured optical data. Two tissue classification algorithms 
developed in this dissertation – SpARC (spectral areas and ratios classifier) algorithm and 
PCA (principal component analysis) algorithm - are described and their performance at 
classifying pancreatic tissue into normal, pancreatitis and adenocarcinoma tissue is 
presented. 
Chapter 6 describes the application of the developed technology to the non-invasive 
assessment of tissue-engineered constructs. Optical spectroscopy measurements and 
Monte Carlo simulations are coupled for optimized non-invasive, quantitative assessment 
employing endogenous contrast. The first part of the chapter describes the first attempt of 
this kind for optical assessment of porcine articular cartilage (AC) tissue samples. These 
samples offer the biological variability not found in artificial tissue-simulating phantoms 
and serve as a model for future optical molecular sensing studies on tissue engineered AC 
constructs intended for use in human therapy. 
The second part of the chapter describes the MC simulations and experiments undertaken 
to optimize the assessment of biological viability of tissue engineered ex vivo produced 
oral mucosa constructs (EVPOME). The first fluorescence spectroscopy measurements of 
EVPOME and its constituents are described. Also described is the first application of 
previously developed Monte Carlo codes to the quantitative simulation of photon 
transport in EVPOME constructs. 
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Chapter 7 summarizes and concludes the dissertation and discusses possible future work 







Chapter 2                                                                
Theoretical Background 
 
A background of the optical techniques employed in this dissertation work is presented in 
this chapter. Section 2.1 of this chapter introduces the theoretical concepts of reflectance 
and fluorescence spectroscopy, including time-resolved fluorescence spectroscopy. 
Section 2.2 briefly describes the previously developed Monte Carlo code of photon 
transport in turbid media.  
2.1  Reflectance and Fluorescence spectroscopy 
When photons impinge on biological tissue, they can undergo a variety of interactions [1, 
2]. Incident photons could be scattered multiple times due to the mismatch of refractive 
indices, be absorbed by chromophores present in the medium (e.g. hemoglobin), or be 
absorbed by fluorophores, which may then release their excess energy by radiative decay, 
producing fluorescence. The remitted fluorescent light may, in turn, be scattered or 
absorbed multiple times.  
Fluorescence and reflectance spectroscopies can provide complimentary information 
about biological tissue. Reflectance spectroscopy provides information primarily about 
tissue morphology (including the size and density of cell nuclei), while fluorescence 
reports mainly on tissue biochemistry (including intra- and extra-cellular endogenous 
fluorophores like NAD(P)H and collagen). These two spectroscopies may be performed 
 15
with thin, flexible, fiber-optic probes; the techniques are thus clinically feasible and allow 
access to internal organs endoscopically or during surgery [10, 25, 35, 47-49]. 
Fluorescence and reflectance spectroscopies have been applied in combination to detect 
oral cancer [50], breast cancer [3], dysplasia in Barrett's esophagus [27], and cervical 
cancer [22]. 
2.1.1 Steady-state reflectance spectroscopy 
As light propagates in a turbid medium, it encounters optical in-homogeneities. Every 
time a refractive index mismatch occurs, light is scattered. If the scattered photon has the 
same energy as the incident photon then light is scattered elastically. Reflectance 
spectroscopy involves the detection of these elastically scattered photons. The 
propagation of elastically scattered (reflected) light is dependant on the characteristic 
features (e.g. size and density of scatterers) of the medium. Thus, reflectance 
spectroscopy can provide pathologically relevant information about living tissues, 
including tissue morphology, as well as the size, shape and, density of cells [2, 5]. Such 
information can help track architectural changes in tissue and has been employed to study 
dysplasia in living tissue [3, 4, 6, 7, 27, 51].  
The instrumentation required for measuring steady-state reflectance spectra in a clinical 
setting typically consists of a light source that gives out white light, and optical fibers for 
delivering the light to the tissue specimen and collecting the scattered signal [27, 52]. A 
spectrograph is used to disperse the intensity spectrum into its various wavelength 
contributions and a charge-coupled device (CCD) camera is then used for detecting the 
signal. As the distance between the source and detector fibers is increased, the light 
scattered from deeper and deeper layers of the tissue can be detected.  
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Figure 2.1 plots a representative normalized reflectance spectrum measured from human 
pancreatic normal tissue (blue line) [6]. A reflectance spectrum is represented as a plot of 
intensity of reflected light, as a function of the wavelength.   
 
Figure 2.1 A representative normalized reflectance spectrum measured from human pancreatic 
normal tissue (blue, solid line) [6]. Also shown are the absorption spectra of oxy-and deoxy-
hemoglobin obtained from [53]. It can be seen that the dips in the pancreatic spectrum correspond 
with the characteristic absorption peaks in hemoglobin at the same wavelengths. 
 
The measured tissue spectrum is affected not only by the size and density of scatterers in 
the tissue but also by chromophores like hemoglobin in blood. Figure 2.1 also plots the 
characteristic absorption spectra of oxy-and deoxy-hemoglobin obtained from [53]. It can 
be seen that the dips in the pancreatic spectrum correspond with the characteristic 
absorption peaks in hemoglobin at the same wavelengths. 
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2.1.2 Steady state and time-resolved fluorescence spectroscopy 
In addition to being scattered or absorbed by chromophores, the light entering tissue may 
be absorbed by certain molecules and excite the molecules to electronically higher states. 
The molecules could then lose some of their energy by non-radiative means and then re-
emit a photon of lower energy. This phenomenon of light emission is called fluorescence 
and the molecules that fluoresce are called fluorophores [10, 11].  
 
Figure 2.2 Jablonski diagram showing the energy level transitions when excitation light is incident 
on a molecule (adapted from [11]). 
 
The processes involved in fluorescence are represented by an energy level diagram 
referred to as the Jablonski Diagram [11] (Figure 2.2). Following light absorption by 
fluorophore molecules, the electrons of the molecule transition from the ground state (S0) 
to higher vibrational states of the first or second excited state (S1, S2). The molecules then 
relax in a time scale of ~ 10-12 seconds to the lowest vibrational level of S1. At this stage, 













Vibrational energy level 
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relax to the ground state, resulting in the emission of fluorescence photons in times 
typically between 10-9 to 10-8 s. The emitted fluorescence photons are typically emitted at 
a larger wavelength (lower energy) than the excitation photons. This change in 
wavelength is referred to as the Stokes shift. The molecules could also relax to the ground 
state by non-radiative decay processes (e.g. collisional quenching). Another possibility is 
the transition of the molecules to a triplet state (T1) by spin conversion, which could then 
eventually relax to the ground state by emitting a phosphorescence photon. This 
transition termed as inter-system crossing is a forbidden transition, which implies that the 
decay rate for such a transition would be very short. As a result, phosphorescence 
photons have a longer lifetime associated with them compared to fluorescence photons. 
A fluorophore is characterized by its fluorescence lifetime and quantum yield [10, 11]. If 
 and kNR are the radiative and non-radiative decay rates (as shown in Figure 2.2), the 
measured fluorescence lifetime τ (which is the average time spent by a molecule in the 
excited state prior to decay to the ground state) can be calculated as,  
τ = 1/ ( + kNR).                - 2.1 
The quantum yield () is defined as the number of emitted photons relative to the number 
of absorbed photons and can be calculated as,  
 =  / ( + kNR).    - 2.2 
The value for  can range from 0 to 1, with a higher value implying brighter 
fluorescence.  
There are two types of fluorescence emission measurements that can be performed - 
steady state (emitted fluorescence intensity as a function of wavelength) and time 
resolved (emitted fluorescence intensity as a function of time). Time-resolved optical 
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spectroscopy and imaging involves delivering a pulse of light to a sample under 
investigation and detecting the transient response of the medium in the time-domain. In 
contrast to time-resolved optical methods steady-state (or, time-integrated) fluorescence 
measurements integrate the signal over time, thus losing an additional dimension of 
information contained in the dynamics of the fluorescence decay.  Fluorophore lifetimes 
are known to be sensitive to the local biochemical environment and to vary with pH and 
oxygenation in a controlled way, but are generally independent of artifacts influencing 
fluorescence intensity, including fluorophore concentration, photobleaching, and sources 
of optical loss (absorption and scattering) in biological systems [11]. This is an important 
issue to consider when applying fluorescence spectroscopy in vivo, since intensity losses 
attributed to hemoglobin absorption in tissue are routinely observed in the lineshape of 
the steady-state emission spectra when measured in vivo [25, 35]. In addition, since 
biomolecules generally have broad and overlapping fluorescence spectral bands, lifetime 
spectroscopy can provide an alternate means of in situ discrimination in multi-
fluorophore systems.  Despite these differences, both methods have been employed for 
differentiating between morphological and biochemical changes in tissue samples. 
Fluorescence methods are useful in biomedical research for several reasons, including the 
molecular specificity of the technique, the relatively large signal strength in regions of the 
electromagnetic spectrum readily accessible to experimentalists, and the many bio-
compatible fluorophores (endogenous and exogenous) available for study. Several 
endogenous bio molecules including amino acids, keratin, flavin adenine dinucleotide 
(FAD) and reduced nicotine amide adenine dinucleotide (NAD(P)H) and collagen are 
naturally fluorescent [9]. Endogenous tissue fluorescence (autofluorescence) provides 
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information about the native biochemical composition and microenvironment in living 
tissues without the use of contrast agents [5, 8-10, 25, 54-56]. 
2.2  Monte Carlo models for tissue photon interactions  
In order to quantify optical measurements made in tissues, it is necessary to accurately 
describe all light-tissue interactions. Analytical treatment of light propagation in tissue is 
possible by considering light to be composed of neutral particles, and applying the 
radiative transport equation to describe photon propagation in such turbid media [57]. A 
common simplification to this approach has been to use the diffusion approximation to 
the radiative transport equation, which yields analytical solutions for the light energy 
distribution, both spatially and temporally, when applied to simple geometries [58-60]. 
The mathematical intractability and the assumptions of analytical approaches are 
significant and have limited the utility of the diffusion theory approximation in 
experiments on tissues that have multiple constituents or complex source configurations. 
A widely used technique for quantitative simulations of light-tissue interactions involves 
the use of Monte Carlo (MC) models for photon transport in turbid media, since they 
provide accurate predictions of light energy distribution in turbid media along with the 
ability to model complex tissue architectures and compositions, as well as source-detector 
geometries [10, 44]. 
Monte Carlo (MC) models for photon transport in turbid media employ tissue and 
fluorophore optical properties to construct photon trajectories in tissue and calculate  
reflectance and fluorescence photons collected at the surface of the tissues for a given 
source and detector fiber geometry. For a tissue with a single fluorophore in a single layer 
the MC code is executed as follows [61]. Excitation photons with a weight of unity are 
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launched from a source fiber normal to the tissue surface. The photons per unit time 
exiting the tissue surface are collected by annuli of detectors placed around the source 
fiber at increasing radii. The weight of the photon is attenuated exponentially as given by 
Beer’s law for the absorption coefficient (a) of the medium. Photon trajectories are 
constructed by stochastic sampling of scattering angles (specified by the anisotropy 
coefficient, g) and path lengths (specified by the scattering coefficient, s of the medium). 
The flight of the photon ends either when it leaves the tissue (by crossing the tissue-air 
interface) or when its weight falls below a threshold minimum value (set to 1x10-5), as 
determined by a Russian roulette routine [62]. At the end of its travel in the tissue, the 
time, t, spent by the photon within the medium was given by t = L/nc, where L is the total 
path-length of the photon, c is the speed of light in vacuum, and n is the refractive index 
of the medium [63].  
If a fluorophore is present in the medium, then the absorption of the excitation photon by 
the fluorophore is governed by the fluorophore absorption coefficients (μafx). Upon 
successful fluorescence absorption, the excitation photon is relabeled a fluorescence 
photon with wavelength m (the emission wavelength of the fluorophore), its new 
direction of travel is determined by an isotropic scattering event, and its weight is 
multiplied by the fluorescence quantum yield . This newly created fluorescence photon 
then continues to propagate from the point of its spatial origin, as governed by the 
scattering, absorption, and anisotropy coefficients of the medium at the fluorescence 
emission wavelength. After each successful fluorescence absorption event, the simulation 
adds a decay time, to the photon's total time of flight to include the effect of a finite 
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fluorophore lifetime (τ). This MC code is further extendible to a tissue with multiple 
fluorophores and multiple layers [61].   
Although the MC model requires a prior knowledge of the medium’s optical transport 
coefficients at wavelengths of interest, it has been shown to be an accurate model for the 
recovery of intrinsic fluorescence from tissue for both steady-state as well as time-
resolved applications [15, 36, 44, 54, 64, 65]. 
In this thesis, a previously developed MC transport code for photon transport in tissue 
media [61] was applied to model photon transport in articular cartilage tissues and to 
assess the fluorescence from EVPOME tissue constructs in order to select appropriate 
excitation wavelength, fiber diameter, and source detector geometry for optimal cellular 
signal detection. Details of the specific MC models used for the articular cartilage and 
EVPOME constructs are described in Chapter 6. 
 
Motivated by the phenomenon discussed in this chapter, a clinically compatible 
instrument was designed for reflectance and fluorescence spectroscopy measurements, 




Chapter 3                                                                
Development of clinically compatible instrumentation 
This chapter describes the Reflectance and Fluorescence Lifetime Spectrometer (RFLS) 
[6, 56] designed and developed in this dissertation work. The RFLS is a portable, 
clinically compatible instrument that employs fiber optic probes for reflectance and 
fluorescence spectroscopy, along with time-resolved fluorescence sensing. The RFLS has 
been inspected for human clinical use by the Biomedical Engineering Unit affiliated with 
the University of Michigan Institutional Review Board (UMIRB) at the UM Hospitals 
and is registered as a non-hospital instrument: UMHS 318435.  
Section 3.1 of this chapter describes the optical components of the RFLS and Section 3.2   
explains the electrical connections. The graphical-user-interface software developed to 
control the RFLS and acquire data remotely is described in Section 3.3. Sections 3.4 and 
3.5 describe the instrument calibration and data processing procedures. The chapter 
concludes with steps undertaken to monitor the performance of the instrument in Section 
3.6.  
3.1  Optical design 
Figure 3.1 shows a schematic of the RFLS. For fluorescence excitation, the RFLS 
employed a pulsed, solid-state laser source (PNV001525-140, JDS Uniphase, San Jose, 
CA) emitting at 355 nm with a 1 KHz repetition rate (500 ps pulse width,15 μJ/pulse). 
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After attenuating pulse energy with a neutral density (ND) filter (ND1), laser light was 
delivered to the sample via an optical fiber.  
 
Figure 3.1 Schematic of the Reflectance and Fluorescence Lifetime Spectrometer (RFLS) (ND – 
neutral density filter, L – lens, LP – long-pass filter, BP- band-pass filter, APD – avalanche photo 
diode, ICCD – intensified charge coupled device). The inset in top left corner shows a schematic 
and photograph of the fiber optic probe employed during pancreatic studies.  
 
For fluorescence spectral measurements, the emitted signal was collected by a detector 
fiber and focused by a series of lenses (L2 and L3) before reaching the detectors. The 
excitation light was eliminated at this stage by placing a long-pass (LP) filter that cut on 
at 387 nm (LP 57345, Spectra Physics, Mountain View, CA). A portion of the 
fluorescence was split off by a ND filter (ND2) and directed towards an avalanche 
photodiode (APD) (C5658, Hamamatsu, Bridgewater, NJ). The time-resolved signal 


























































































Tektronix, Beaverton, OR). The rest of the fluorescence was sent to a spectrograph (MS 
125, Oriel Instruments, Stratford, CT) coupled intensified charge coupled device (ICCD) 
camera (ICCD 2063, Andor Technology, Belfast, Northern Ireland) for spectral data 
detection.  
For reflectance measurements, light from a tungsten halogen lamp (HL 2000FHSA, 
Ocean Optics, Dunedin, FL) with continuous wave (CW) output between 360-2000 nm 
was delivered to the sample by a third identical optical fiber (reflectance source fiber). 
Reflectance measurements were made by blocking light from the laser by employing the 
shutter (S) and opening the shutter in front if the lamp. The scattered photons were 
detected by the detector fiber and directed as before to the spectrograph coupled ICCD 
camera for detecting the reflectance spectra. 
Fluorescence and reflectance measurements were made sequentially by blocking out the 
light from the other source. For each spectral measurement a background signal was first 
collected by blocking the source lights and then that background was subtracted from the 
acquired data signal to give the background subtracted signal. 
The light from both sources was delivered to the sample using separate optical fibers and 
the signal from the sample was collected and delivered to the detectors via a third 
identical detection optical fiber. The size and geometry of the fiber probes could be 
varied depending on the application [66]. For example, the distance between the source 
and detector fibers could be changed to probe varying depths into the sample. For the 
pancreatic cancer study, at the distal end, the fiber probe was comprised of the three 
fibers placed adjacent to each other in a triangular geometry (Figure 3.1, inset) 
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(customized fiber probe, Ocean Optics). The fibers had 600 µm core diameter and 0.22 
numerical aperture (NA). 
 
Figure 3.2 The electrical connections on the Reflectance and Fluorescence Lifetime Spectrometer 
(RFLS) (ND – neutral density filter, L – lens, LP – long-pass filter, BP- band-pass filter, APD – 
avalanche photo diode, ICCD – intensified charge coupled device). 
 
3.2  Electronic design 
Figure 3.2 is a schematic of the electrical connections employed for triggering the laser 
source, gating the ICCD camera, and triggering the oscilloscope during data acquisition. 
A medical grade isolation transformer was employed to electrically isolate the RFLS for 
compliance with University of Michigan IRB regulations for conducting human clinical 

















































































using software written in LabVIEW (LabVIEW 7.1, National Instruments, Austin, TX) as 
described in Section 3.3.  
3.2.1 Laser triggering and shutter control 
The pulsed 355 nm laser excitation source was triggered to emit optical pulses by 
employing electrical pulses generated using a timer/counter (T/C) board (PCI-6602, 
National Instruments, Austin, TX). The T/C board was programmed to emit pulses at 1 
KHz repetition rate of 55 microsecond duration. The trigger signal from the T/C board 
was sent via a connector block (CB-68LPR, National Instruments) to the laser. 
As mentioned in Section 3.1, fluorescence and reflectance measurements were made 
sequentially by blocking out the light from the other source. While the lamp had an 
inbuilt shutter, the laser light was blocked when required by employing a home-built 
shutter (S). The shutter for the laser was built by attaching light blocking material to a 
rotatory solenoid (H-2744-032, Testco, San Jose, CA) that was controlled by the T/C 
board. To control the shutter, signals were sent from the T/C board via the connector 
block and a relay box (SC-2062, National Instruments) to the solenoid which then rotated 
to open or close the shutter. An appropriately light-weight material was employed for 
blocking light to ensure that the solenoid could rotate easily and not malfunction due to 
over-heating. The in-built reflectance lamp shutter was also controlled employing the T/C 
board by sending signals from the board via the connector block and relay box to the 
lamp shutter. 
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3.2.2 Gating of the ICCD 
To minimize background signal during fluorescence spectra acquisition, the ICCD gating 
was synchronized with the arrival of the fluorescence signal. A portion of the trigger 
signal to the laser was input to a home built pulse conditioner (described previously [67]), 
which provided a stable TTL pulse output. The TTL pulse was then input to a delay 
generator (DG535, Stanford Research Systems, Sunnyvale, CA) that introduced a 175 μs 
gate delay and 30 μs gate width in the ICCD with respect to the triggering of the laser. 
These setting corresponded with the time delay between the emission of the laser 
excitation pulse and when the emitted fluorescence reached the ICCD camera (gate 
delay) and the duration of the emitted fluorescence (gate width). These settings would 
need to be changed if a significantly longer or shorter fiber probe is employed for data 
collection. 
Typically, a few 100 ns at most should be an appropriate gate width to capture the 
transient fluorescence from endogenous fluorophores. However, the gate width had to be 
set to 30 μs due to an inherent temporal jitter in the output from the laser. In addition, the 
laser was not left on for periods longer than 2 hours at a time, as this would lead to a 
thermal drift in the laser pulse emission time which in turn would have required changing 
the gate delay parameter.  
3.2.3 Triggering of the oscilloscope 
The oscilloscope was externally triggered to synchronize the sampling of the time-
resolved fluorescence signal acquired by the APD with the emission of the laser 
excitation pulse. A ND filter (ND3) of optical density 0.03 was employed to direct a 
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portion of the emitted laser light to a second photodiode (DET10, Thorlabs) (Figure 3.2). 
The signal from this photodiode was employed as an external trigger to the oscilloscope.  
3.3   Software 
A graphical user interface (GUI) program was developed in LabVIEW for data collection 
using the RFLS. The developed GUI enabled remote, fully automated acquisition and 
storage of fluorescence and reflectance data sequentially. The software had the following 
functions:  
– The GUI provided easy access to instrument acquisition parameters including gate 
width, gate delay, number of data acquisitions to average (spectral and time-
resolved), and ICCD chip exposure times for both fluorescence and reflectance 
acquisition.  
– The GUI enabled the automated storage of fluorescence and reflectance spectral data 
and fluorescence life-time decays with a date and time stamp into folders chosen by 
the user. 
– The GUI provided control of the energy of laser excitation photons reaching the 
sample (ND1) and the fraction of light transmitted to the ICCD for spectral detection 
(ND2). This was achieved by employing motorized rotating filter wheels (FW102, 
Thor Labs) remotely controlled via the GUI. Six ND filters of varying optical density 
could be positioned on each of the filter wheels thus providing a choice of 6 ND1 and 
6 ND2 filter to choose from. This enabled the detection of optimized optical signals 
with low noise and without the risk of saturating the detectors (ICCD and APD) due 
to excessive signal. 
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– The software remotely controlled the laser and lamp shutters and enabled the 
acquisition of a background spectrum prior to data acquisition. The user could then 
choose to either store background subtracted or raw measured spectral data. 
– Prior to data acquisition, the software cooled the ICCD head to -5 oC to decrease dark 
noise in the ICCD camera chip. After data acquisition, the software ensured a 
controlled increase of the ICCD temperature to avoid thermal stress in the output 
optical fibers on the intensifier of the ICCD. 
3.4  Instrument calibration 
The RFLS was calibrated for wavelength and absolute fluorescence and reflectance 
spectral intensity by employing procedures in [67]. These procedures are briefly 
described below. 
Wavelength calibration was performed to assign wavelength values to each of the 1024 
pixels on the ICCD camera of the RFLS. An Hg(Ar) lamp (6035, Oriel Instruments, 
Stratford, CT) with emission lines at known wavelengths was employed. The lamp 
emission was measured using the RFLS and the ICCD pixel number corresponding to 
each known emission line was noted. The pixel numbers and the corresponding emission 
wavelengths were then employed to assign a wavelength to each pixel of the ICCD 
camera of RFLS. 
The RFLS spectral instrument response S(λ) was calculated by measuring the emission 
from a National Institute of Standards and Technology traceable tungsten halogen lamp 
(63355 S.N. 7-1329, Oriel Instruments) and dividing it by the known theoretical spectrum 
provided by Oriel Instruments. Calibration for the spectral instrument response was then 
achieved by dividing measured spectra by S(λ). 
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3.5  Data processing 
For fluorescence and reflectance spectral measurements, a background spectrum was 
acquired with the sources blocked and was subtracted from the detected sample spectrum. 
Background subtracted data were then corrected to give distortion free spectra by 
calibrating the wavelength and correcting for the spectral instrument response of the 
RFLS as described in Section 3.4  and in [67]. 
Reflectance spectra were also corrected for the intensity spectrum of the lamp. First, the 
lamp spectrum was measured by placing a diffuse reflectance standard (SRS-50-010, 
Labsphere, North Sutton, NH) in lieu of the tissue sample. Next, the background 
subtracted and instrument response corrected sample reflectance spectrum (Rsample) was 
divided by the background subtracted and instrument response corrected lamp spectrum 
(R0), to give the reflectance spectrum (R) (i.e. R = Rsample / R0). 
The RFLS also has a temporal instrument response due to the finite pulse width of the 
laser excitation pulse and response of the electronics. Measured time resolved 
fluorescence decays M(t) were interpreted as a convolution of the intrinsic fluorescence 
decay,  f(t), and the temporal instrument response function, I(t): i.e. M(t) = f(t)  I(t) as 
detailed in [67]. The instrument response function I(t) was measured using the scatter of 
the excitation pulse by a dilute solution of silica spheres (Bangs Laboratories, Inc., 
Fishers, IN).The intrinsic fluorescence decay (f(t)) was then calculated by least-squares 
iterative reconvolution (Light Analysis software, Quantum Northwest, Inc., Spokane, 
WA), where f(t) was modeled as a multi-exponential decay:  f(t) = ∑ ci exp (-t/τi). The 
average decay time τ, was then calculated as τ = ∑ci* τi
2/ ∑c1i* τ1i. Section 3.6 shows an 
example of time-resolved fluorescence data analyzed in this manner. 
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3.6  Monitoring the performance of the RFLS 
The RFLS is a portable device that was transported to the surgery suites for data 
acquisition. It was necessary to ensure that the calibration of the instrument and the 
alignment of the optics were not disturbed during these trips and that data from 
measurements made on multiple days could be relied upon. Measuring fluorophore 
standards along with laser output energy and the lamp spectrum R0 as detailed in Section 
3.5 helped to monitor the performance of the RFLS instrument. 
Spectral measurements: 
Prior to, and post data acquisition, solutions of 1 µM Rhodamine B (R6626, Sigma 
Aldrich, St. Louis, Missouri) in DI water and 1 µM Fluorescein (166308, Aldrich) in de-
ionized (DI) water were measured to ensure the wavelength and spectral instrument 
response had not changed. These solutions were also measured by employing a 
spectrofluorometer (Fluorolog-3, Horiba Jobin Yvon) as well as the RFLS measurements 
The Fluorolog-3 is described in detail in Section 4.1.3. The measurements from the two 
instruments were compared to check the wavelength calibration and spectral instrument 
response of the RFLS. Figure 3.3 plots a typical measurement of Fluorescein and 
Rhodamine B fluorescence measured by employing the Fluorolog-3 (dotted lines) and 
RFLS (solid lines) instruments.  
The coincidence of the location of the peaks indicated that the wavelength calibration of 
the RFLS was correct and the coincidence of the spectral shapes indicated that the 




Figure 3.3 Plot of the fluorescence spectrum of solutions of 1 µM Rhodamine B in water (blue) 
and 1 µM Fluorescein in water (red) measured by employing the Reflectance and Fluorescence 
Lifetime Spectrometer (RFLS) (solid lines) and the Fluorolog-3 spectrofluorometer (dotted lines). 
 
Time resolved fluorescence measurements: 
Freshly prepared solutions of 1µM POPOP (P3754, Sigma Aldrich) in cyclohexane and 
1µM Rhodamine B in DI water were measured before and after data acquisition and the 
extracted decay times were compared to literature values for these single exponential 
decay fluorophores (1.58  0.08 ns, for Rhodamine B in water and 1.12  0.02 ns, for 
POPOP in cyclohexane) [68]. Figure 3.4 plots a time-resolved fluorescence decay curve 
measured employing the RFLS from Rhodamine B in water (red dashed line). The 
instrument response of the RFLS (solid black line) is labeled ‘‘Excitation’’ and was 
measured with a dilute solution of silica spheres as described in Section 3.5. Data were fit 
to a single exponential decay [67]. The plot also shows the residual between the 
measured fluorescence and the simulated fit (labeled “Simulation”). 
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An example of the mean  standard deviation decay times extracted from two successive 
fluorescence decay measurements of Rhodamine B and POPOP are: 1.49  0.01 ns and 
1.05  0.01 ns, respectively. These extracted decay times were in good agreement with 
the literature values.  
 
 
Figure 3.4  Time-resolved fluorescence of 1 µM Rhodamine B in water (red dashed line) 
measured employing the RFLS. Data were fit to a single exponential decay (green dotted line, 
labeled “simulation”) with a lifetime of 1.5 ns. The instrument response of the RFLS (solid black 
line) is labeled ‘‘Excitation’’ and was measured with a dilute solution of silica spheres.  
 
 
Thus, a clinically compatible, fiber optic coupled instrument was developed for 
measuring reflectance and fluorescence spectra and time-resolved fluorescence decay 

































measurements from human pancreatic tissues, (Chapter 4) human pancreatic xenografts 
in mice (Chapter 4), porcine articular cartilage (Chapter 6), and tissue engineered oral 




Chapter 4                                                             
Optical spectroscopy for pancreatic adenocarcinoma detection 
Pancreatic adenocarcinoma is a leading cause of cancer death with a five-year survival 
rate of only 5%. Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA), the 
current diagnostic standard, cannot reliably rule out malignancy, and is insensitive to 
distinguishing adenocarcinoma from chronic pancreatitis (inflammation). In this study, 
for the first time, we tested the ability of multi-modal optical spectroscopy to detect 
signals from pancreatic tissue by studying human pancreatic cancer xenografts in mice 
and freshly excised human pancreatic tissues, and correlated measured optical spectra and 
fluorescence decays with pathology [6, 69]. Section 4.1 describes the in vivo and ex vivo 
mouse studies of human pancreatic xenografts in mice and presents the results of the 
study. Section 4.2 describes the ex vivo measurements of human pancreatic cancer tissue 
during pancreatic surgeries. The section discusses the histopathology of the measured 
sites and presents the spectral data. The section also presents the time-resolved 
fluorescence data measured on a limited data set.  
4.1  Optical spectroscopy of human pancreatic xenografts in mice 
4.1.1 Pancreatic cancer xenografts in mouse models 
Cultured human pancreatic cancer cells derived from mouse xenografts initiated with 
cells from a patient with pancreatic adenocarcinoma (AsPC-1, American Culture 
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Collection Type, Manassas Virginia) were cultured in RPMI 1640 medium with 2 mM L-
glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM 
HEPES, and 1.0 mM sodium pyruvate and 10% fetal bovine serum at 37oC with 5% CO2 
on 100mm plates. Cells were grown to 80% confluence, harvested by trypsinization, 
washed with medium and 10% fetal bovine serum, and re-suspended to a final 
concentration of 1 x 106 cells/ml in sterile phosphate buffered saline. 
4 week old male NOD/SCID mice (non-obese diabetic/severe combined 
immunodeficiency) were housed in a sterile environment. Cages, bedding, food, and 
water were all autoclaved. All animals were maintained on a daily 12-hr light/12-hr dark 
cycle. The animals were anesthetized using 100 mg/kg ketamine and 15 mg/kg of 
xylezene injected intraperitoneally. The abdomen was opened via a 2 cm midline 
incision, and the tail of the pancreas was exposed. The pancreas was then injected with 
105 AsPC-1 cells suspended in 100 l of sterile phosphate buffered saline solution. The 
midline wound was then closed in 2 layers.    
For optical characterization of the tumor, 3 weeks after tumor injection, the mice were 
anesthetized using 100 mg/kg ketamine and 15 mg/kg of xylezene injected 
intraperitoneally. The abdomen was opened laterally to the previous 2 cm midline 
incision, and the tail of the pancreas exposed. The first mouse had a 0.4 cm mass in the 
pancreas. The second had a 0.7 cm mass in the tail of the pancreas.  In vivo reflectance 
and fluorescence spectroscopy measurements were made on the tumors by employing the 
RFLS. The tumors were then resected and a spectrofluorometer was employed to obtain 
ex vivo fluorescence excitation-emission matrices. The animal study was approved by the 
University of Michigan Committee on Use and Care of Animals.  
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4.1.2 In vivo RFLS measurements 
Reflectance and fluorescence spectral data were obtained using the Reflectance and 
Fluorescence Lifetime Spectrometer (RFLS) (described in Chapter 3). Briefly, for 
fluorescence measurements, a pulsed 355 nm excitation source was employed. A 
tungsten halogen lamp was employed as the reflectance source. The fluorescence and 
reflectance spectra were collected using a spectrograph coupled intensified charge 
coupled device (ICCD) camera. The light from both sources was delivered sequentially to 
the sample using separate optical fibers (600 micron core) (SFS600/660 Fiberguide 
Industries) and the signal from the sample was collected and delivered to the 
spectrograph via a third identical fiber. At the distal end, the three fibers were placed in a 
triangular geometry. Figure 4.1 shows the fiber probe placed on the pancreas of a 
NOD/SCID mouse during in vivo RFLS measurements. 
 
Figure 4.1 NOD/SCID (non-obese diabetic/severe combined immunodeficiency) mouse pancreas 
with human pancreatic cancer xenograft during in vivo measurement [6]. Measurements were 




All measured spectra were background subtracted and corrected for the spectral 
instrument response. The measured reflectance spectra were also scaled by the measured 
intensity spectrum of the lamp (Ro) to get the corrected reflectance spectra (R/Ro). Details 
of the calibration are described in Chapter 3. All corrected fluorescence and reflectance 
spectra were then normalized by scaling the peak intensity to unity. 
The gray solid line in Figure 4.2 shows in vivo fluorescence measured from a human 
pancreatic cancer xenograft grown in one of the mice. The measured fluorescence peaked 
around 460 nm indicating predominant fluorescence from NAD(P)H [9].  
 
Figure 4.2 The fluorescence spectrum of in vivo adenocarcinoma xenograft in a mouse model 
(gray solid line). Reflectance spectrum of adenocarcinoma xenograft is also shown (black dashed 
line). Measurements were made employing the clinically compatible reflectance and fluorescence 
lifetime spectrometer (RFLS). 
 
In general, pancreatic tumor tissue is expected to have excess fibrosis. Thus, predominant 
fluorescence emission associated with collagen might be expected. However, since SCID 
mice were employed, due to their immunodeficiency, the expected fibrosis associated 
with tumor tissue was absent. Thus, the measured xenograft fluorescence could be 






























associated primarily with the cellular component of the grown tumor (mainly NAD(P)H) 
and corresponded well with the fluorescence attributed to the cellular signal in the human 
study (results in Section 4.2.2). The black dashed line in Figure 4.2 shows an in vivo 
reflectance spectrum measured from the same human pancreatic xenograft. The spectrum 
showed characteristic hemoglobin absorption dips at approximately 400–440 and 540–
580 nm as was discussed in Section 2.1.1 [28]. 
4.1.3 Ex vivo spectrofluorometer measurements 
The pancreatic cancer xenografts grown in the mice were resected after the in vivo 
measurements and excitation emission matrices (EEMs) were measured using a 
spectrofluorometer (SPEX® FL3-22 Fluorolog-3, Jobin-Yvon Horiba, Japan). The 
Fluorolog-3 spectrofluorometer was equipped with a 450 W Xe short arc lamp source 
that was focused onto a tunable, double excitation spectrometer (Czerny-Turner 
1200/mm kinematic grating blazed at 330 nm) to produce a monochromatic collimated 
excitation beam at the sample at any desired wavelength from 290-900 nm. Emitted 
fluorescence was collected perpendicular to the excitation direction, collimated, and 
dispersed by a tunable double emission spectrometer (Czerny-Turner 1200/mm kinematic 
grating blazed at 500 nm) into a multialkali photomultiplier tube detector. The system 
was interfaced to a computer via custom software which allowed an automated scanning 
of the sample via measurement of an excitation spectrum, an emission spectrum, or 
combined EEM spectra. The tumor samples were front illuminated at a 45o angle to the 
excitation beam to obtain the EEM for 20 excitation wavelengths between 300 and 450 
nm while monitoring the emission from 300 to 650 nm (at 2 nm increments). 
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Figure 4.3a shows EEM data acquired ex vivo from the pancreatic cancer xenograft 
grown in one of the mice. The EEM fluorescence intensity pattern was consistent with 
endogenous tissue fluorescence predominantly originating from tryptophan (peak 
emission about 350 nm), intracellular NAD(P)H (peak emission about 460 nm) along 
with some fluorescence from extracellular collagen (peak emission about 400 nm) [5, 8-
10, 25, 54-56]. Figure 4.3b shows this EEM data around excitation wavelength 355 nm, 
which was the wavelength employed for excitation in RFLS studies. As was observed in 
the in vivo measurements, the measured fluorescence peaked around 460 nm indicating 
predominant fluorescence from NAD(P)H for 355 nm excitation, as was expected since 
the mice were immunodefficient and so the expected fibrosis usually associated with 
tumor tissue was absent.  
 
Figure 4.3 (a) Measured EEM of a pancreatic cancer xenograft grown in a NOD/SCID mouse 
showing fluorescence emission primarily associated with tryptophan, extracellular collagen, and 
intracellular NAD(P)H [69]. (b) Same EEM expanded to highlight the area between white dashed 
lines in (a) showing fluorescence emission primarily associated with collagen and NAD(P)H. 
RFLS excitation in the human studies occurred at 355 nm (white dotted line) [69]. The EEM data 
was measured on the Fluorolog-3 spectrofluorometer.  
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4.2  Ex vivo optical spectroscopy of human pancreatic tissues 
Reflectance and fluorescence spectra and time-resolved fluorescence decays were 
measured from freshly excised human pancreatic tissues obtained during pancreatic 
surgical procedures, by employing the fiber optic coupled RFLS. Figure 4.4 shows the 
fiber optic probe (discussed in Section 3.1) placed on human pancreatic tissue during data 
acquisition. A total of 90 sites were measured on tissues obtained from 12 patients within 
30 minutes of excision. Table 4.1 shows the details of the patients’ age, gender, and final 
diagnosis of the resected specimen. Two sets of fluorescence and reflectance 
measurements were made on each site, excepting one site.  After data acquisition from 
each measurement site, a tissue biopsy was immediately performed to link optical 
measurements with histopathologic analysis. The study was approved by the Institutional 
Review Board of the University of Michigan (U of M) and written patient consent was 
obtained prior to data acquisition. 
 
Figure 4.4 Human pancreatic tissue during ex vivo measurement [6]. Measurements were made 
employing the clinically compatible reflectance and fluorescence lifetime spectrometer (RFLS).  
 
 
The acquired fluorescence spectra were corrected for spectral instrument response after 
background correction [67]. The reflectance spectra were also background subtracted and 
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then scaled by the lamp reflectance spectrum (Ro) to obtain the corrected reflectance 
spectra (R/Ro) [56]. All spectra were normalized by scaling the peak intensity value to 
unity. 
 
Table 4.1. Patient information and final diagnosis 
Patient Age M/F Final Diagnosis 
1 68 F Adenocarcinoma 
2 41 F Adenocarcinoma 
3 79 F Adenocarcinoma 
4 54 M 
Intraductal papillary mucinous neoplasm, adenoma type. No 
invasive carcinoma identified. Chronic pancreatitis. 
5 69 M Serous cystadenoma 
6 53 F 
Lipomatous pseudohypertrophy with foci of fat necrosis.  
Background pancreas with mild patchy chronic pancreatitis 
7 60 M 
Intraductal papillary mucinous neoplasm with high grade dysplasia. 
No invasive carcinoma was identified. Chronic pancreatitis 
8 69 F Adenocarcinoma 
9 70 M Adenocarcinoma 
10 63 F Chronic Pancreatitis 
11 65 F Adenocarcinoma 
12 76 F Metastatic breast adenocarcinoma 
 
4.2.1 Histopathology and inclusion criterion 
Figure 4.5 shows representative histology slides of samples obtained from sites with (a) 
normal, (b) chronic pancreatitis, and (c) adenocarcinoma tissue after RFLS optical 
measurements. The images were taken at 200x magnification. Hematoxylin and eosin 
(H&E) were used as the staining agent. The light pink in the slides denotes the stroma or 
extra cellular matrix (ECM) where collagen resides while the nuclei, where NAD(P)H 





Figure 4.5. Shows representative histology slides [69] of human tissue obtained from -  (a) 
Normal pancreatic tissue [A - normal component of fibrous stroma between pancreatic lobules; B - 
small interlobular pancreatic duct; C- normal pancreatic lobule with acinar cells having abundant 
granular cytoplasm and little intervening stroma]. (b) Chronic pancreatitis tissue [D- acinar cells 
separated by abundant fibrous stroma and inflammation; E- abundant interlobular inflamed fibrous 
tissue; F- white blood cells having small dark nuclei (shown in small circles)]. (c) 
Adenocarcinoma tissue [G - adenocarcinoma cell groups surrounded by abundant fibrous stroma; 
H - adenocarcinoma cells having enlarged dark nuclei, and arranged in duct-like structures]. (200 


















The normal pancreatic tissue histology (Figure 4.5a) shows normal component of fibrous 
stroma between pancreatic lobules (A), small interlobular pancreatic duct (B), and normal 
pancreatic lobule with acinar cells having abundant granular cytoplasm and little 
intervening stroma (C).  
Chronic pancreatitis is associated with an increase in fibrosis (mainly collagen) due to 
inflammation. This also leads to more white blood cells (lymphocytes) in the tissue. This 
is evident in Figure 4.5b where abundant interlobular inflamed fibrous tissue (E – light 
pink) can be seen along with white blood cells having small dark nuclei (F- shown in 
small circles). Acinar cells were now observed separated by abundant fibrous stroma and 
inflammation (D) unlike in the normal tissue.  
Figure 4.5c shows adenocarcinoma cell groups surrounded by abundant fibrous stroma 
just like in the pancreatitis tissue (G). However unlike pancreatitis, adenocarcinoma cells 
have enlarged, dark nuclei (H). In the figure, the cells can be seen arranged in duct-like 
structures. This observed increase in fibrosis and excess collagen in both chronic 
pancreatitis and adenocarcinoma tissue, and an increase in the nuclear size in 
adenocarcinoma cells, was expected to affect the optical measurements made on these 
tissues. 
Histopathology indicated that of the 90 measured sites from 12 patients, 17 were 
adenocarcinoma sites, 22 were chronic pancreatitis sites, and 11 were normal tissue sites. 
The remaining 40 sites were either malignant breast cancer that had metastasized to the 
pancreas (10 sites), intraductal papillary mucinous neoplasm (8 sites), pancreatic 
intraepithelial neoplasia (6 sites), serous cystadenoma (8 sites), scar or fat tissue or both 
(5 sites), or a hybrid tissue site having two or more of the above mentioned pathologies (3 
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sites). These 40 sites were excluded from the data set used for tissue classification 
algorithm development in Chapter 5. Their analysis will be considered in the future, once 
a larger data set is in place. Table 4.2 indicates the pathology of the measured sites, for 
each patient. The numbers in green indicate the sites that were included in algorithm 
development while red indicates the excluded data. 
 
Table 4.2. Patient-wise histology of the sites from which data was collected  
(Red: excluded data; Green: included data) 








1 2 3 - - - - - - - - 
2 - - 5 - - - - - - - 
3 - 5   - 1 - - - 1 1  
4 - 3 - - 1 - - 1 - - 
5 - - - - - 8 - - - - 
6 4 - - 1 - - - - - - 
7 - - - - 7 - - 1 - - 
8 - 4 1 1 - - - - 1 1 
9 5 1 1 3 - - - - - - 
10 - 6 - - - - - 2 - - 
11 - - 10 - - - - - - - 
12 - - - - - - 10 - - - 
N: Normal; P: Pancreatitis; A : Adenocarcinoma; PanIN : Pancreatic Intraepithelial Neoplasia; 
IPMN: Intraductal papillary mucinous neoplasm; SCA : Serous Cyst Adenoma; MBC:  
metastatic breast carcinoma 
a: A hybrid tissue site of chronic pancreatitis and adenocarcinoma;  
b: A hybrid tissue site of  focal adenocarcinoma at the edge of mostly normal tissue 
 
Furthermore, fluorescence spectra with signal to noise ratio (SNR) less than 25 (two 
spectra) were excluded from the data set. SNR was calculated as mean signal at peak 
fluorescence divided by the standard deviation of noise in the data (SNR = (average 
intensity between 470-500 nm) / (standard deviation of intensity between 700-750 nm)). 
Reflectance spectra that had a ratio of reflectance at 550 nm to that at 650 nm less than 
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0.1 were also excluded from the data set (one spectrum).  The corresponding fluorescence 
and reflectance spectra of these spectra were also excluded, resulting in the exclusion of 3 
pairs of fluorescence and reflectance spectra. 
This left data from 9 patients and 50 sites: 33 pairs of measured reflectance and 
fluorescence spectra from adenocarcinoma, 41 pairs of spectra from chronic pancreatitis 
measurements, and 22 pairs of spectra from measurements of normal pancreatic tissue. 
These 96 pairs of measured reflectance and fluorescence spectra were used for the 
development of tissue classification algorithms (discussed in Chapter 5). 
The corresponding 96 time-resolved fluorescence decays were obtained by detecting 
either: (a) fluorescence emission from 360-750 nm (76 measurements) or, (b) 
fluorescence emission from 500-750 nm (20 measurements). Analysis was restricted to 
the 76 measurements from category (a), as all category (b) measurements were from 
adenocarcinoma sites only. Of these 76 measurements, 19 were excluded due to initial 
errors (subsequently resolved) in triggering the oscilloscope during data acquisition. This 
left 57 time-resolved fluorescence decay measurements, of which, 4 were made on 
adenocarcinoma sites, 35 were made on chronic pancreatitis sites, and 18 were made on 
normal pancreatic tissue sites. Considering the small number of adenocarcinoma 
measurements in this subset, tissue classification algorithm development was limited to 
the remaining 18 normal and 35 chronic pancreatitis tissue time-resolved fluorescence 
decays (results in Section 4.2.3). 
4.2.2 Spectral data 
Figure 4.6 shows the mean of normalized measured reflectance and fluorescence spectra 
for adenocarcinoma (red dashed line), chronic pancreatitis (green dot-dashed line), and 
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normal (blue solid line) pancreatic tissues along with the standard error at select 
wavelengths.  
 
Figure 4.6 (a) Mean fluorescence spectra obtained from human pancreatic normal (blue), 
pancreatitis (green dot-dash), and adenocarcinoma (red dashed) tissues. (b) Mean reflectance 
spectra obtained from normal (blue), pancreatitis (green dot-dash) and adenocarcinoma (red 
dashed) tissues. N denotes the number of individual spectra. The standard error is shown at select 
wavelengths [70]. 
 
Tissue fluorescence spectra revealed cellular NAD(P)H (emission around 460 nm) and 
extracellular matrix collagen (emission around 400 nm) and characteristic hemoglobin 
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absorption dips at around 420, 540, and 575 nm in the reflectance and fluorescence 
spectra [55, 56]. The relative collagen emission from adenocarcinoma and chronic 
pancreatitis tissues was larger than that from normal tissues, as anticipated from the 
increase in fibrosis in the diseased tissues [71]. The cellular fluorescence corresponded 
well with the fluorescence attributed to the cellular signal in the mouse study ((Figure 
4.2, gray solid line).  
Features in the 400–440 and 540–580 nm ranges in both fluorescence and reflectance 
spectra could be attributed to hemoglobin absorption [28]. The adenocarcinoma sites 
showed a higher reflectance than chronic pancreatitis and normal tissue sites in the 430 to 
500 nm range. Such tissue reflectance features have been associated with both the density 
and size of cellular scatterers (e.g. nuclei and organelles) [28, 72]. Indeed, this reflectance 
feature was observed in the data obtained from xenograft tumor in mice (Figure 4.2, 
black dashed line) and corresponded well with measurements made on human 
adenocarcinoma. 
4.2.3 Time-resolved fluorescence data 
As described in Section 4.2.1, analysis of the time-resolved fluorescence decay 
measurements was restricted to a limited data set comprising of 35 chronic pancreatitis 
and 18 normal tissue measurements. Figure 4.7a plots the mean of the normalized 
measured time-resolved fluorescence decay curves from these pancreatitis (green, dashed 
line) and normal (blue, solid line) tissue sites.  
Figure 4.7b plots the same data on a logarithmic scale to enhance for viewing purposes 
the difference between the decay curves of the two tissue types. 
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All the measured time resolved data were interpreted as a convolution of the instrument 
response curve with the intrinsic fluorescence decay curve (f(t)) as described in Section 
3.5 [67].  The instrument response was measured using the scatter of the excitation pulse 
by a dilute solution of silica spheres.  f(t) was interpreted as a triple exponential decay of 
the form f(t) = ∑ exp(-aiti/τi), (i = 3) with lifetimes τi and amplitudes ai. The average 
decay time was defined as τavg = a1τ1
2 + a2τ2
2 + a3τ3
2 / (a1τ1 + a2τ2+ a3τ3). 
 
 
Figure 4.7 (a) Mean normalized time-resolved fluorescence decay, measured from chronic 
pancreatitis (green dashed line, 35 measurements) and normal (blue solid line, 18 measurements) 
pancreatic tissue sites. (b) The plot on a logarithmic scale zoomed with the standard error shown at 
a select time point. 
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The mean τavg was 4.5 ± 1.7 for chronic pancreatitis tissue (35 measurements), and 3.3 ± 
0.9 ns for normal tissue (18 measurements). Wilcoxon rank sum test of the decay times of 
normal and chronic pancreatitis tissue indicated a difference in the median decay times of 
the tissues (p-value = 0.0078).  The relative excess of collagen emission from chronic 
pancreatitis vs. normal tissue corresponded well with this increase in fluorescence decay 
time measured for all chronic pancreatitis tissues vs. all normal tissues [69], which was 
attributed to the longer excited-state lifetime associated with collagen compared to 
NAD(P)H [36]. 
4.3  Conclusion 
The ability of multi-modal optical spectroscopy to detect signals from pancreatic tissue 
was demonstrated by studying human pancreatic cancer xenografts in mice and freshly 
excised human pancreatic tumor tissue for the first time. The EEM matrices measured 
from human pancreatic cancer xenografts in mice enabled a complete characterization of 
pancreatic adenocarcinoma tissue and indicated the expected fluorophores in the tissue. 
The mouse study indicated that 355 nm was an appropriate excitation wavelength to 
excite fluorescence from the pathologically relevant endogenous fluorophores in the 
pancreas. Good correspondence was observed between spectra from human pancreatic 
adenocarcinoma and cancer xenograft tissues.  Measured optical spectra and fluorescence 
decays were correlated with tissue morphological and biochemical properties. The 
measured spectral features and decay times correlated well with expected pathological 
differences in human normal, pancreatitis and adenocarcinoma pancreatic tissue states. 
The observed differences between the fluorescence and reflectance properties of normal, 
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pancreatitis and adenocarcinoma tissue indicated a possible application of multi-modal 
optical spectroscopy for differentiating between the three tissue classifications. The next 
chapter describes the development of tissue classification algorithms employing the 




Chapter 5                                                              
Development of tissue classification algorithms for the 
detection of pancreatic adenocarcinoma 
A number of chemometric and statistical techniques have been applied to develop tissue 
classification algorithms employing optical spectroscopy data. These include multiple 
linear regression analysis, linear discriminant analysis (LDA), neural network analysis, 
principal component analysis (PCA), logistic discrimination, partial least squares, 
multivariate linear regression, and support vector machine [4, 7, 19-23].  
This chapter describes the development of the first ever algorithms for pancreatic tissue 
classification using multi-modal optical spectroscopy data [70, 73, 74]. In this 
dissertation, LDA was employed to classify pancreatic tissues using classification 
variables extracted from the measured optical reflectance and fluorescence data described 
in Chapter 4. Two different tissue classification algorithms were developed based on the 
classification variables [70, 73, 74]. The first was the SpARC (spectral areas and ratios 
classifier) algorithm that employed ratios of intensities at different wavelengths and areas 
under the measured spectral curves, thus using information only at specific 
wavelengths[70]. The second algorithm was the principal component analysis (PCA) 
algorithm that employed diagnostically relevant information at all wavelengths of the 
spectra for tissue classification [73]. The PCA algorithm was also employed on the 
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limited data set of time-resolved fluorescence spectra (described in Section 4.2.1). 
Section 5.1 of this chapter introduces LDA. Section 5.2 describes the SpARC algorithm, 
presents the results of the algorithm’s classification performance, and compares it with 
that of EUS-FNA, the current accepted diagnostic standards for pancreatic 
adenocarcinoma (discussed in Section 1.2.1). Section 5.3 describes the development of 
the tissue classification algorithm employing PCA and LDA and reports the performance 
of the PCA algorithm for pancreatic tissue classification. Section 5.3 also discusses a 
framework for automated detection of pancreatic adenocarcinoma using multi-modal 
optical spectroscopy and the developed PCA algorithm and makes a comparison of the 
PCA algorithm performance with EUS-FNA.  
5.1  Linear discriminant analysis  
Linear discriminant analysis (LDA) [20, 75-77] is a classification technique in which a 
classification score (Z) is calculated based on a linear combination of the classification 
variables (Vi).  
Z =  b + a1V1 +a2V2 + …….+ akVk.    - 5.1 
Where, k is the number of classification variables, and b and ai are the coefficients 
calculated such that the distance between the classification scores of the same group is 
minimized, while maximizing the distance between the classification scores of different 
groups. 
An unknown specimen could then be classified into a group based on it’s proximity to the 
centroid of the classification score of that group. For a two group problem, this proximity 
can either be measured by deciding a cut-off point (i.e. Z > cut-off implies belongs to 
group 1, else group 2) or by calculating the probabilities of the unknown specimen 
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belonging to a group given that a score Z was obtained using the LDA model. The 
specimen would then be classified as belonging to the group for which the probability is 
highest.  
The  LDA model for classification can be developed either by employing all variables 
specified by the user (Direct LDA) or the set of variables that provide the best 
classification can be selected from the given variables using selection criterion (for 
example, Wilks’ Lambda (Λ) criterion) that assess the discriminating power of the 
variables. The latter DA is called a stepwise DA. At each step, variables are considered 
for the classification algorithm only if the p-value (representing the discrimination added 
by the variable) satisfies the P-to-enter significance criterion (set by the user). Out of 
those variables, the variable that minimizes Λ is selected. At the next step, all variables 
that have already entered the algorithm are re-assessed to see if any of them no longer 
sufficiently discriminate between the classification groups (measured by a P-to-remove 
value). This is repeated until no variables satisfy the P-to-enter criterion. The variables 
retained at the end by the stepwise analysis are then employed to classify the data.  
5.2  Spectral areas and ratio classifier (SpARC) algorithm 
The SpARC algorithm was developed based on the differences in the fluorescence and 
reflectance spectra of normal, chronic pancreatitis, and adenocarcinoma human 
pancreatic tissue types (Figure 4.6 in Chapter 4). The adenocarcinoma sites showed 
markedly higher reflectance than chronic pancreatitis and normal tissue sites between 450 
to 540 nm, higher fluorescence at around 400 nm, and lower fluorescence between 450 to 
700 nm. Due to the ex vivo nature of the study, it is difficult to draw conclusions on 
differing hemoglobin absorption between tissue types. The observed spectral differences 
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are consistent with increased cellular nuclear size and collagen content in pancreatic 
adenocarcinoma tissues [72]. To classify the tissue spectra based on these apparent 
differences, the ratio Rratio = R470/R650 was calculated for each reflectance spectrum, the 
wavelength integrated fluorescence (Farea) was calculated as the area under each 
normalized fluorescence spectrum, and the ratio Fratio = F400/F600, was calculated for each 
normalized fluorescence spectrum.   
Three different sets of these calculated spectral parameters (“classification variables”) 
were employed to develop tissue classification algorithms for distinguishing (a) 
adenocarcinoma (A) from chronic pancreatitis (P) and normal (N) tissue, (b) A from P 
tissue, (c) A from N tissue, and (d) P from N tissue. A leave-one-out cross-validation was 
undertaken to test the performance of the proposed tissue classification algorithms by 
considering each measured spectrum as the test data and by employing the remaining 
spectra as training data in the classification algorithm. LDA was employed using SPSS 
software to classify the test data using the three different sets of classification variables. 
This process was repeated for each spectrum and the sensitivity, specificity, negative 
predictive value (NPV), and positive predictive value (PPV) of the classification 
algorithms were calculated. 
5.2.1 Classification performance of the SpARC algorithm and 
comparison to EUS-FNA 
The first classification algorithm, RSpARC (reflectance spectral areas and ratios 
classifier), employed Rratio as the sole classification variable for LDA and Table 5.1 gives 
the algorithm’s performance. The second algorithm, FSpARC (fluorescence spectral 
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areas and ratios classifier), employed Farea and Fratio as the classification variables for 
LDA and Table 5.2 gives that algorithm’s performance.  
In the third algorithm, SpARC (spectral areas and ratios classifier), stepwise LDA was 
performed (as described in Section 5.1) using minimization of Wilks’ Lambda (Λ) 
criterion (P-to-enter 0.085; P-to-remove 0.1) to assess the discriminating power of the 
variables and to select the best set of variables from Rratio, Farea, and Fratio for 
classification [77]. The variables retained by the stepwise analysis were employed to 
classify the data. Table 5.3 shows the performance of this algorithm along with the 
variables retained for each classification. For example, classification of A vs. (P and N) 
employed Rratio and Fratio. 
 




Specificity    
(%) 
NPV      
(%) 
PPV        
(%) 
A vs. P and N 85 86 92 76 
A vs. P 85 83 87 80 
A vs. N 88 95 84 97 
P vs. N 56 82 50 85 
 
 




Specificity   
(%) 
NPV     
(%) 
PPV        
(%) 
A vs. P and N 55 89 79 72 
A vs. P 52 88 69 77 
A vs. N 58 91 59 90 
P vs. N 56 64 44 74 
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Specificity    
(%) 
NPV      
(%) 
PPV      
(%) 
A vs. P  and Na,b 85 89 92 80 
A vs. Pa 85 83 87 80 
A vs. Na 88 95 84 97 
P vs. Na,c 61 73 50 81 
Classification parameters a: Rratio
  ; b: Fratio
  ; c: Farea 
 
 For A vs. (P and N) and P vs. N classification, the combination of classifiers extracted 
from both reflectance and fluorescence (Table 5.3) performed better than using 
information from either just reflectance (Table 5.1) or just fluorescence (Table 5.2), 
indicating that for the SpARC algorithm, bi-modal optical spectroscopy with both 
fluorescence and reflectance is required for accurate pancreatic tissue classification. 
Based on the results in Table 5.3, a potential method for classifying an unknown tissue 
site could employ Rratio and Fratio to classify the data set as adenocarcinoma or not 
adenocarcinoma using LDA. If the data is classified as not cancer, then Rratio and Farea 
could be employed to classify it as chronic pancreatitis or normal tissue types. 
Hartwig et al. [30], conducted a meta-analysis of 28 EUS-FNA studies, and reported 
median (range) values of sensitivity 83% (54 -96%); specificity 100% (71-100%); NPV 
72% (16-92%); and PPV 100% (92-100%) for adenocarcinoma distinction from normal 
tissue and chronic pancreatitis. The performance of the SpARC algorithm for 
adenocarcinoma distinction from normal tissue and chronic pancreatitis (Table 5.3, row 
1) is comparable to that of the reported performance of EUS-FNA. Fritscher-Ravens et 
al. [31] studied patients having both adenocarcinoma and pancreatitis and reported that 
EUS-FNA had a 54% sensitivity, 100% specificity, 91% NPV, and 100% PPV for 
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distinguishing adenocarcinoma from pancreatitis in the setting of pancreatitis. All 
adenocarcinoma measurements in the study reported here were also made on pancreata 
that had concurrent histologic pancreatitis in addition to the carcinoma. Thus, the 
sensitivity of SpARC (85%) (Table 5.3, row 2) is well above that of EUS-FNA (54%) 
[31] at distinguishing adenocarcinoma from pancreatitis in the setting of pancreatitis, 
which is an unmet clinical need in pancreatic cancer detection. The receiver operating 
curves (ROC) for A vs. (P and N) (area 0.901 ± 0.043) and A vs. P (area 0.874 ± 0.047) 
classification using the SpARC algorithm were calculated using SPSS software and are 
shown in Figure 5.1. The blue line suggests that in achieving a specificity of close to 
100%, the A vs. P sensitivity would be comparable to EUS-FNA. Thus, employing an 
optical technique to guide EUS-FNA could improve the sensitivity of pancreatic 
adenocarcinoma detection in the setting of pancreatitis. 
 
Figure 5.1 The receiver operating curves (ROC) for A vs. (P and N) (black, dashed line) and A vs. 
P classification (blue, dotted line) using the SpARC algorithm, where the areas under the ROCs 

















SpARC A vs. P and N
SpARC A vs. P
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Although the SpARC algorithm is simple to implement, its performance may be limited 
because it utilizes information at only select wavelengths. Section 5.3 describes the 
development and classification performance of a PCA algorithm that employed 
diagnostically relevant information at all wavelengths for classification. 
5.3  Principal component analysis (PCA) algorithm 
In this algorithm, principal component analysis (PCA) was used to identify the diagnostic 
features in the spectra and then LDA was employed to classify the data based on these 
features. PCA and LDA analyses were also conducted on a subset of the data that 
included time-resolved fluorescence decay measurements in addition to spectral 
measurements (subset defined in Section 4.2.1). 
 
Figure 5.2 Steps in the PCA tissue classification algorithm development [73]. (PCA: principal 
component analysis; PC: principal component; LDA: linear discriminant analysis; PPV: positive 
predictive value; NPV: negative predictive value) 
 
Fluorescence and reflectance intensity 
data at n different wavelengths.
PCA gives n components. 
Select PCs that account for at least 
99.5% variance in the data.
Wilcoxon rank-sum tests identify 
diagnostically relevant PCs.
LDA employs subsets of the 
diagnostically relevant PCs.




Figure 5.2 illustrates the steps involved in the tissue classification algorithm 
development. The acquired spectra were first analyzed using PCA. The principal 
components (PCs) that accounted for at least 99.5% of the variance in the data were then 
identified. Wilcoxon rank-sum tests were performed on the fit-coefficients of these PCs 
for each tissue type to identify the diagnostically relevant PCs as described in Section 
5.3.1. Linear discriminant analysis was then undertaken using various subsets of the 
diagnostically relevant PCs (Section 5.3.2) to classify the spectral data employing leave-
one-out cross validation. These procedures are detailed below.  
5.3.1 Principal component analysis of the spectra 
PCA was employed to express each measured spectrum as a linear combination of a set 
of orthogonal basis vectors (or principal components (PC)) [4, 7, 19, 21, 78, 79]. The 
spectra 1 ni Rs  (i = 1 to m) for different tissue types were grouped together and 
arranged row-wise in a matrix nmRS   as shown below: 






































































     - 5.2 
 
Where, p, q and r (p+q+r=m) are the number of spectra for adenocarcinoma, chronic 
pancreatitis and normal pancreatic tissue, respectively. Using PCA, n-dimensional data 
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set (corresponding to the n measured wavelengths) with m total spectra was represented 
as a linear combination of n basis vectors as shown below:  
     ,CXST                   - 5.3 
Where, T is the transpose operator, nnRC   is the matrix of the n principal components, 





























   - 5.4 
 
Where, an element xji is the fit-coefficient of the j
th component for the ith spectrum. 
The principal component matrix C was obtained from S by employing the princomp 
function in MATLAB.  The princomp function first calculates matrix S0 by subtracting 
the column mean vector from each row of S. Then singular value decomposition is used 
to calculate the principal components as the eigenvectors of the sample covariance matrix 
(
00
1)1( SSm T ). The princomp command also calculates the eigenvalues corresponding to 
each principal component. The columns of X were estimated by fitting the principal 
components to the spectra using an ordinary least squares method (the backslash operator 
in MATLAB). The vectors of estimated fit-coefficients for each spectrum (i.e. the 
columns of X) were then separated into three groups based on the tissue type. This 
analysis was done separately for both fluorescence (n = 492) and reflectance spectra (n = 
521). Figure 5.3a and Figure 5.3b plot select fluorescence and reflectance PCs extracted 
from the spectral data.  
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Figure 5.3 Select PCs extracted from (a) fluorescence and (b) reflectance spectra of pancreatic 
adenocarcinoma, chronic pancreatitis, and normal tissues. The percent eigenvalues of the extracted 
PCs for (c) fluorescence and (d) reflectance spectra [73]. 
 
5.3.2 LDA of diagnostically relevant principal components (PCs) 
Key spectral features of the data were captured by only a few of these PCs (having higher 
eigenvalues), while the vectors corresponding to lower eigenvalues typically represented 
noise in the data. Figure 5.3c and Figure 5.3d plot the percent eigenvalues (or percent 
variance) of the fluorescence and reflectance PCs. The higher the percent value, the more 
the corresponding PC explained the variance in the data. However, not all the key 
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features of the spectra are diagnostically relevant (i.e. enabling differentiation between 
the tissue types). Wilcoxon rank-sum tests were employed to identify the PCs whose fit-
coefficients showed differences between tissue types and were thus diagnostically 
relevant.  
The PCs for which the fit-coefficients were significantly different between the tissue 
types were determined based on a two-sided Wilcoxon rank-sum test (p < 0.05).  This test 
was done for the PCs that accounted for at least 99.5% of the variance in the data (Figure 
5.3c and Figure 5.3d). The first 11 fluorescence PCs accounted for at least 99.5% of the 
variance in fluorescence data and the first 8 reflectance PCs accounted for at least 99.5% 
variance in the reflectance data. Four Wilcoxon rank-sum tests were performed for the 
fit-coefficients of these PC. The hypothesis tested was that the median fit-coefficients 
were significantly different for the principal component of: (1) adenocarcinoma (A) vs. 
the rest of the tissue types; (2) A vs. chronic pancreatitis (P); (3) A vs. normal pancreatic 
tissue (N); (4) P vs. N. The PCs for which the p-values of the Wilcoxon rank-sum tests 
were less than 0.05 were considered diagnostically relevant. This analysis was done for 
both fluorescence and reflectance spectra separately to determine the PCs whose fit-
coefficients would be used for classification of tissue types: RPC, diagnostically relevant 
reflectance PC; FPC, diagnostically relevant fluorescence PC. The PCs plotted in Figure 
5.3a and Figure 5.3b are some of the diagnostically relevant RPC and FPC we identified 
in this study. 
LDA was employed using SPSS software to distinguish between tissue types using the 
fit-coefficients of the diagnostically relevant RPC and FPC as classification variables. 
The analysis was undertaken by employing the fit-coefficients of three different sets of 
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diagnostically relevant PCs: reflectance PC only, fluorescence PC only, or a combination 
of the reflectance and fluorescence PC variables. In the latter case, a stepwise DA (P-to-
enter ≤ 0.05; P-to-remove value ≥ 0.25) was performed using minimization of Wilks’ 
Lambda (Λ) criterion to assess the discriminating power of the variables and to select the 
best set of variables from diagnostically relevant RPC and FPC for classification.  
A leave-one-out cross-validation was undertaken to test the performance of each of the 
proposed tissue classification algorithms. For each algorithm, the data were divided into 
training and test data where each pair of reflectance and fluorescence spectra were 
considered as test data one at a time, while the remaining spectra were treated as training 
data. The classifiers were then employed to classify the test data using LDA. Each 
algorithm was implemented 96 times and sensitivity, specificity, NPV, and PPV were 
calculated. 
5.3.3  PCA and LDA employing time-resolved fluorescence 
measurements 
As described in Section 4.2.1, analysis of the time-resolved fluorescence decay 
measurements was restricted to a limited data set comprising of 35 chronic pancreatitis 
and 18 normal tissue measurements. Figure 5.4a plots on a logarithmic scale the mean of 
the normalized measured time-resolved fluorescence decay curves from these pancreatitis 
and normal tissue sites. PCA was employed on the normalized time-resolved 
fluorescence decays of this limited data set with the premise that the shape of the decay 
curve should reflect changes in decay time for different tissue types, assuming the 
temporal instrument response did not change. PCA was also employed on the 
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fluorescence and reflectance spectral data for the same subset of chronic pancreatitis and 
normal tissue data.  
 
Figure 5.4 (a) The plot of mean normalized time-resolved fluorescence decay, measured from chronic 
pancreatitis (green dashed line) and normal (blue solid line) pancreatic tissue sites on a logarithmic 
scale. (b) Select PCs extracted from these time-resolved fluorescence decays [73]. 
 
The first 12 fluorescence spectral PCs and first 5 time-resolved fluorescence PCs 
accounted for at least 99.5% of the variance in the spectral and time-resolved 
fluorescence data, respectively. The first 7 reflectance PCs accounted for at least 99.5% 
variance in the reflectance data. The diagnostically relevant spectral fluorescence, 
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spectral reflectance, and time-resolved fluorescence PCs (FPC′, RPC′, and TRPC′, 
respectively) were determined as before using Wilcoxon rank-sum tests on these PCs that 
explained at least 99.5% variance of this limited data set. (The ′ symbol denotes PCs 
extracted from the limited data set).  
A stepwise LDA (P-to-enter = 0.09; P-to-remove = 0.1) was performed on the fit-
coefficients of these diagnostically relevant FPC′s, RPC′s, and TRPC′s, to distinguish 
between chronic pancreatitis and normal tissue sites. The analysis was undertaken by 
employing three different sets of diagnostically relevant PCs: only fluorescence and 
reflectance spectral data PCs, only time-resolved data PCs, or a combination of the 
spectral and time-resolved data PCs. A leave-one-out cross validation was implemented 
for each of these sets of PCs and sensitivity, specificity, NPV, and PPV were calculated. 
Figure 5.4b plots some of the diagnostically relevant TRPC′s extracted from the time-
resolved fluorescence data. 
5.3.4 Classification performance of the PCA algorithm  
5.3.4.1 Classification using fluorescence and/or reflectance spectra 
Three different set of classification variables were employed to develop the chemometric 
tissue classification algorithm: diagnostically relevant fluorescence PCs only, reflectance 
PCs only, or a combination of the fluorescence and reflectance spectra PCs. 
Classification results are summarized below. 
Classification using fluorescence parameters 
Table 5.4 lists the performance of the chemometric algorithm for classifying tissue types 
using only the diagnostically relevant fluorescence PC. The diagnostically relevant PCs 
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were identified by Wilcoxon rank-sum tests as described in Section 5.3.2. For example, 
for distinguishing adenocarcinoma from chronic pancreatitis and normal tissue FPC1, 
FPC4, FPC6, and FPC11 (some of which are shown in Figure 5.3a) were employed and 
sensitivity, specificity, NPV, and PPV of 82%, 78%, 89%, and 66%, respectively were 
achieved.  




Specificity    
(%) 
NPV      
(%) 
PPV      
(%) 
Components 
A vs. P & N 82 78 89 66 FPC1, FPC4, FPC6, FPC11 
A vs. P 79 73 81 70 FPC1, FPC2, FPC11 
A vs. N 88 91 83 94 FPC1, FPC4, FPC6,FPC8, FPC9 
P vs. N 56 73 47 79 FPC7, FPC8, FPC9 
A: adenocarcinoma (33 spectra); N: normal (22 spectra); P: pancreatitis (41 spectra) 
 




Specificity    
(%) 
NPV      
(%) 
PPV    
(%) 
Components 
A vs. P & N 94 84 96 76 RPC1, RPC2 
A vs. P 79 88 83 84 RPC1, RPC2, RPC7, RPC8 
A vs. N 94 86 90 91 RPC1, RPC2 
P vs. N 78 82 67 89 RPC1, RPC3, RPC5, RPC7, RPC8
A: adenocarcinoma (33 spectra); N: normal (22 spectra); P: pancreatitis (41 spectra) 
 
Classification using reflectance parameters 
Table 5.5 lists the sensitivity, specificity, NPV and PPV for classifying tissue types using 
only the diagnostically relevant reflectance PCs. For example, for distinguishing 
adenocarcinoma from chronic pancreatitis and normal tissue, LDA was performed on the 
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fit-coefficients of RPC1, and RPC2 (shown in Figure 5.3b). The classification 
performance of the algorithm using reflectance PCs only was found to be better at 
classifying the tissue types than the algorithm using fluorescence PCs only.  
 
Classification using fluorescence and reflectance parameters  
The third set of classification variables was comprised of the diagnostically relevant PCs 
from both fluorescence and reflectance spectra. Table 5.6 lists the sensitivity, specificity, 
NPV, and PPV for classifying tissue types using both diagnostically relevant fluorescence 
PCs and reflectance PCs, where a stepwise LDA was performed (as described in Section 
5.3.2) to further select classification variables from all the diagnostically relevant 
fluorescence and reflectance PC listed in Table 5.4 and Table 5.5. The last column in 
Table 5.6 indicates the PCs selected by the stepwise LDA for the classification 
procedure. Figure 5.3a and Figure 5.3b show some of the diagnostically relevant PC used 
for this classification. The results in Table 5.6 indicate that a combination of reflectance 
and fluorescence PCs has the best sensitivity and specificity for identifying pancreatic 
adenocarcinoma.  
 




Specificity    
(%) 
NPV      
(%) 
PPV      
(%) 
Components 
A vs. P & N 91 90 95 83 RPC1, RPC2, FPC1, FPC4, FPC6
A vs. P 82 85 85 82 RPC1, RPC2, RPC8, FPC1 
A vs. N 94 86 90 91 RPC1, RPC2 
P vs. N 83 86 73 92 RPC1, RPC5, RPC7 
A: adenocarcinoma (33 spectra); N: normal (22 spectra); P: pancreatitis (41 spectra) 
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The receiver operating curves (ROCs) for A vs. (P and N) (area 0.923 ± 0.040) and A vs. 
P (area 0.908 ± 0.036) classification using the PCA algorithm employing both 
fluorescence and reflectance parameters were calculated using SPSS software and are 
shown in Figure 5.5. 
 
Figure 5.5 The receiver operating curves (ROC) for A vs. (P and N) (black, dashed line) and A vs. 
P classification (blue, dotted line) using the PCA algorithm, where the areas under the ROCs were 
0.923 ± 0.040 and 0.908 ± 0.036, respectively. The gray dotted line indicates the line of no 
discrimination [73]. 
 
5.3.4.2 Inclusion of time-resolved fluorescence data 
The effect of including diagnostically relevant time-resolved fluorescence data PCs was 
evaluated on the limited data set of 18 normal and 35 pancreatitis tissue measurements, as 
described in Section 4.2.1. Table 5.7 lists the sensitivity, specificity, NPV, and PPV for 
classifying chronic pancreatitis vs. normal tissue types employing stepwise LDA on: 
diagnostically relevant fluorescence and reflectance spectral data PCs only (results in row 
1), time-resolved data PCs only (row 2), or a combination of the spectral and time-
resolved data PCs (row 3). For example, for distinguishing chronic pancreatitis from 
normal tissue using time-resolved data PCs only, the stepwise LDA employed the fit-
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coefficients of TRPC′1, TRPC′3, and TRPC′5 (shown in Figure 5.4b). The results of this 
analysis on the limited data set indicated that using a combination of both spectral and 
temporal information (results in row 3 of Table 5.7) significantly improved the 
classification performance of the chemometric algorithm for distinguishing pancreatitis 
from normal pancreatic tissue (compared to row 4 of Table 5.6). 
 
Table 5.7. Chronic pancreatitis vs. normal pancreatic tissue classification using spectral and/or 




Specificity    
(%) 
NPV     
(%) 
PPV    
(%) 
Components 
P vs. N 80 83 68 90 RPC′1, RPC′5, RPC′7, FPC′9 
P vs. N 80 89 70 93 TRPC′1, TRPC′3, TRPC′5 
P vs. N 89 100 82 100 RPC′1, RPC′5, RPC′7, FPC′9, TRPC′5 
N: normal (18 measurements); P: pancreatitis (35 measurements) 
  
5.3.4.3 . Framework for automated clinical detection of pancreatic 
disease using optical spectroscopy and the PCA algorithm 
The results in Table 5.6 showed that a combination of reflectance and fluorescence 
parameters had the best sensitivity, specificity, and PPV for identifying adenocarcinoma. 
In addition, the NPV of 95% was nearly identical to 96% for algorithm employing RPCs 
only. Based on these results, data from an unknown tissue site could be classified in a 
two-step chemometric algorithm as illustrated in Figure 5.6. First, the test data could be 
classified by employing RPC1, RPC2, FPC1, and FPC4, FPC6 into ‘adenocarcinoma’ or 
‘not adenocarcinoma’. If the data is classified as ‘not adenocarcinoma’ then, if needed, 
RPC1, RPC5, and RPC7 could be employed to further classify the data into ‘normal’ or 
‘chronic pancreatitis’. Employing PCA and LDA on the limited time-resolved 
 72
fluorescence data set indicated improved classification of chronic pancreatitis vs. normal 
tissue with the use of both spectral and time-resolved data. If this result holds true in a 
larger data set, as well, then time-resolved fluorescence PCs could also be included in the 
classification algorithm.  
Our results suggest that using the optical technique in conjunction with EUS-FNA could 
significantly improve the sensitivity of pancreatic adenocarcinoma detection in the setting 
of chronic pancreatitis. In a clinical setting, such a chemometric classification procedure 
could be undertaken in a few seconds, giving a quick, automated classification scheme 
either to guide EUS-FNA procedures or to improve tumor margin detection during 
pancreatic surgery.  
 
Figure 5.6 The proposed tissue classification algorithm schematic for unknown data. 
5.3.4.4 Comparison of the developed PCA algorithm with current 
diagnostic standard, EUS-FNA 
As mentioned previously, EUS-FNA has median (range) values of 83% (54 -95%) 
sensitivity, 100% (71-100%) specificity, 72% (16-92%) NPV, and 100% (92-100%) 
PPV, for adenocarcinoma identification according to a recent meta-analysis of 28 studies 




RPC1, RPC2, FPC1, FPC4, FPC6
RPC1, RPC5, RPC7
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the developed optical tissue classification PCA algorithm for correctly identifying 
adenocarcinoma were 91%, 90%, 95%, and 83%, respectively. Thus, the classification 
performance of the developed optical algorithms for adenocarcinoma identification is 
comparable to the reported performance of EUS-FNA. In the setting of pancreatitis, i.e. 
when the patient has both adenocarcinoma and chronic pancreatitis, EUS-FNA has a 
reported sensitivity, specificity, NPV, and PPV of 54%, 100%, 91%, and 100% 
respectively [31] for distinguishing adenocarcinoma from chronic pancreatitis. The 
sensitivity is unacceptably low, being only slightly better than the outcome of a coin toss. 
All adenocarcinoma measurements in the study reported here were also made on 
pancreata that had concurrent histologic pancreatitis in addition to the carcinoma. For 
distinguishing adenocarcinoma from chronic pancreatitis, the PCA algorithm had a 
sensitivity, specificity, NPV, and PPV of 82%, 85%, 85%, and 82% respectively. Thus, 
the sensitivity of the optical PCA algorithm is well above that of EUS-FNA, indicating a 
decreased likelihood of obtaining false negative results. Our results suggest that using the 
optical technique in conjunction with EUS-FNA could significantly improve the 
sensitivity of pancreatic adenocarcinoma detection in the setting of chronic pancreatitis. 
In a clinical setting, such a classification procedure could be undertaken in a few seconds, 
giving a quick, automated classification scheme either to guide EUS-FNA procedures or 
to improve tumor margin detection during pancreatic surgery.  
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Chapter 6                                                             
Non-invasive characterization of tissue engineered devices 
using optical spectroscopy 
 
Tissue engineered constructs are functional biologic devices employed for grafting 
wounds or replacing diseased tissue. Non-invasive methods are required to assess the 
viability of these engineered constructs. In this chapter, the prospect of employing the 
developed optical spectroscopy instrumentation and previously developed Monte Carlo 
(MC) simulations to non-invasively and quantitatively investigate endogenous optical 
signals from tissue engineered devices was assessed. The methods developed in this 
chapter have the significant advantage of being safe for clinical human use as they 
employ endogenous contrast. 
In Section 6.1, a method to non-invasively and quantitatively characterize thick 
biological tissues by combining experimental and computational approaches in tissue 
optical spectroscopy was developed and validated on porcine articular cartilage (AC) 
tissue samples [13, 56]. This work and the methods developed here should aid in the 
future study of AC tissue constructs. To the best of our knowledge, this study is the first 
to couple non-invasive reflectance and fluorescence spectroscopic measurements on 
freshly harvested tissues with MC computational modeling of time-resolved propagation 
of both excitation light and multi-fluorophore emission. Section 6.1.1 describes the 
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histology and sample preparation of the porcine AC samples measured in this study. 
Sections 6.1.2 and 6.1.3 describe the fluorescence and reflectance spectra and time-
resolved fluorescence decay measurements made on porcine AC. Section 6.1.4 describes 
the extraction of tissue optical properties of AC and Section 6.1.5 describes the MC 
simulations that were run using these tissue optical properties. Section 6.1.6 then presents 
the results of the optical measurements and simulations and introduces a method to 
couple the two for non-invasive assessment of tissues using endogenous contrast agents. 
Section 6.2, presents the work done in this dissertation to optimize non-invasive optical 
assessment of cell viability in ex vivo produced oral mucosa equivalent (EVPOME) 
constructs [80]. In this work, fluorescence spectral measurements and Monte Carlo 
simulations were executed for the first time to characterize the optical signatures in 
EVPOME and to optimize fluorescence signal form the cellular component of EVPOME 
in order to assess the viability of the constructs pre- and post- implantation into patients.  
Section 6.2.1 describes the manufacturing procedure and histology of EVPOME 
constructs and Section 6.2.2 discusses the expected fluorescence optical signatures in an 
EVPOME construct. Section 6.2.3 describes the MC simulations of photon transport in 
EVPOME constructs executed at 355 nm and 450 nm excitation for different source-
detector fiber geometries. The Section also describes the tissue optical properties and 
fluorophore optical properties employed as inputs to the MC simulations. Section 6.2.5  
describes measurement of EVPOME constructs employing the reflectance and 
fluorescence lifetime spectrometer (RFLS). Section 6.2.6 presents the results of the MC 
simulations and experimental measurements. Section 6.2.7 concludes the chapter with a 
discussion of the results obtained and possible future directions for the study. 
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6.1  Porcine articular cartilage (AC): towards the assessment of AC 
constructs 
6.1.1 Porcine knee articular cartilage (AC) sample preparation 
Hyaline AC is found in the synovial joints and is composed of chondrocytes surrounded 
by extracellular matrix, which is mainly composed of tissue fluid (80% water) and a 
macromolecular framework composed of collagens (mainly collagen type II, 90% – 
95%), proteoglycans, and non-collagenous proteins and glycoproteins [45]. Figure 6.1 
shows a micrograph of porcine knee AC tissue made by using an antibody based 
immunochemical stain (C7510-20F, United States Biological, Swampscott, MA) that 
specifically stains collagen type II in brown color. Cells and remaining tissue components 
not containing collagen type II appeared green in the figure. 
 
Figure 6.1  Immunohistochemical staining for collagen type II (brown) found in the extracellular 
matrix (ECM) (blue arrows) of porcine knee articular cartilage (AC) [56]. Red arrows indicate 




Sixteen porcine knee AC samples (approximately 1-2 mm in thickness) were either 
freshly harvested (with measurements done 1-2 hours after harvesting) or cultured in 
culture media composed of Dulbecco's modified Eagle's medium (11995-065, 
Gibco/Invitrogen, Carlsbad, CA) + 10% fetal bovine serum (16000-044, 
Gibco/Invitrogen) + 1% penicillin/streptomycin (15140-122, Gibco/Invitrogen) for 1 
week before measurements were taken. These two groups of samples were employed to 
determine whether culturing would affect tissue optical response.  No marked differences 
were observed between the two groups. All samples were washed in phosphate-buffered 
saline (Cat. No.110010-023, Invitrogen) to remove traces of blood and cell culture media, 
placed on 0.88 mm thick quartz microscope slides (01018-AB, Structure Probe Inc., West 
Chester, PA) and sealed inside imaging chamber gaskets (C-18160, Invitrogen) for 
experimental measurements. Two of the samples (cultured) were used to extract tissue 
scattering and absorption coefficients via integrating sphere (IS) measurements 
(described in Section 6.1.4). The remaining fourteen samples were employed for steady-
state and time-resolved fluorescence measurements. Reflectance measurements were 
performed on eleven out of these fourteen samples and a fluorescence excitation-
emission matrix (EEM) was acquired using one of the other three samples (as described 
in Section 6.1.2).  
6.1.2 Spectrofluorimetry 
A spectrofluorometer (SPEX® FL3-22 Fluorolog-3, Jobin-Yvon Horiba, Japan) was 
employed to measure the EEM for AC tissue. Details of the Fluorolog-3 
spectrofluorometer can be found in Section 4.1.3. The AC sample was front illuminated 
to obtain the EEM for 25 excitation wavelengths between 320 and 450 nm while 
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monitoring the emission between 340-650 nm (at 1 nm increments). Data acquisition 
time was approximately 6 minutes.  
6.1.3 Reflectance, steady-state fluorescence and fluorescence lifetime 
spectrometer measurements 
The Reflectance and Fluorescence Lifetime Spectrometer (RFLS) described in Chapter 3 
was employed to measure reflectance and fluorescence spectra and time-resolved 
fluorescence decays from AC tissues. Light from the fluorescence laser and reflectance 
lamp sources were delivered to the sample via two identical optical fibers (fluorescence 
and reflectance source fibers) (SFS600/660N, Fiberguide Industries, Stirling, NJ) of 600 
µm core diameter and 0.22 numerical aperture (NA). At the distal end, the fiber probe 
was comprised of these two source fibers and a third, identical detector fiber placed 
adjacent to each other in a triangular geometry (as shown for the probe in Figure 3.1). 
Fluorescence and reflectance measurements were acquired sequentially. 
For reflectance measurements, the LP and ND2 filters in Figure 3.1 were removed and 
the optical signal from the sample was sent via the detector fiber and focusing optics 
directly to the spectrograph-coupled ICCD camera. The ICCD camera was run in its 
internal mode (i.e. the gate was open throughout data acquisition) and room lights were 
turned off to minimize background signal. 
For fluorescence and reflectance measurements, a background spectrum was acquired 
with the sources blocked and was subtracted from the detected sample spectrum. 
Background subtracted data were then corrected to give distortion free spectra in units of 
photon numbers by calibrating the wavelength and correcting for the spectral instrument 
response of the RFLS. Details of these calibration procedures were described earlier in 
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Section 3.4 of Chapter 3 [67]. Reflectance spectra were also corrected for the intensity 
spectrum of the lamp. First, the lamp spectrum was measured by placing a ND filter of 
OD 0.03 (03FNQ002, Melles Griot, Rochester, NY) in lieu of the tissue sample. Next, the 
background subtracted and instrument response corrected tissue sample reflectance 
spectrum (Rsample) was divided by the background subtracted and instrument response 
corrected lamp spectrum (Rlamp), to give the reflectance spectrum (R) from each AC 
tissue sample (i.e. R = Rsample / Rlamp). 
In this study, all measurements were taken with the fiber optic probe oriented normal to, 
and at a slight distance (0.5-1.0 cm) above, the AC tissue surface to mimic likely 
experimental conditions for studies on sterile samples. Reflectance spectra were 
measured keeping the ICCD gate open for 380 µs and steady-state fluorescence spectra 
were measured by averaging over 1600 pulses (1.6 s integration time). For fluorescence 
measurements, laser pulse energy was attenuated using an ND1 filter of optical density 
(OD) 1.0 (03FNQ015, Melles Griot).  
Three set of time-resolved fluorescence measurements were made on each sample: one 
full spectrum measurement (using the LP filter) and two wavelength-selected 
measurements (using BP filters (centered at 400 and 540 ± 10 nm) in place of the LP 
filter). All time-resolved fluorescence measurements were collected by averaging over 50 
pulses. All measured fluorescence decays M(t) were interpreted as a convolution of the 
intrinsic fluorescence decay,  f(t), and the instrument response function, I(t) [67], where 
f(t) was modeled as a double exponential decay:  f(t) = ∑ ci exp (-t/τi), (i = 1,2) because  
the AC tissue was considered to be composed of a long-lived (collagen) and a short-lived 
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(NADH) fluorophore. The average decay time τ, was calculated as τ = [(c1* τ1
2+ c2* τ2
2)/ 
(c1* τ1+ c2* τ2)]. 
 
Figure 6.2 Spectrally weighted fluorescence emission W(λ) (see text) for two 
fluorophores in the AC tissue [56]. These spectra were measured on the RFLS for 
powdered collagen II (blue line) and for 70 M NADH in DI-H2O (red dashed line). The 
black dashed lines indicate the spectral position of band-pass filters that were employed 
for obtaining time-resolved fluorescence measurements from porcine AC samples. 
 
 
Figure 6.2 shows the spectral positions of the BP filters (black dashed lines) relative to 
the spectrally weighted fluorescence emission W(λ) of collagen (blue line, solid) and 
NADH (red line, dashed). These fluorescence emission spectra were acquired on the 
RFLS from NADH (N-8129, Sigma Aldrich) in DI-H2O (70 µM) and collagen type II (C-
1188, Sigma Aldrich) in powder form. In order to calculate W(λ) each measured 
fluorescence spectrum was normalized by setting the maximum fluorescence emission 
intensity to unity (thus getting rid of fluorophore concentration effects), then scaled such 
that area under each curve was unity, and finally multiplied by the quantum yield (QY) 
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of the corresponding fluorophore (0.15 for collagen and 0.1 for NADH obtained from 
literature [36, 81, 82]). As seen in Figure 6.2, at BP 400 nm, collagen dominated the 
fluorescence emission relative to NADH, while at BP 540 nm, this was reversed. Thus, 
the effects of the changes in the measured fluorescence decays from a medium containing 
these two fluorophores (NADH and Collagen II), obtained via these two BP filters could 
be quantitatively modelled using a Monte Carlo model (described below in Section 6.1.5  
below). 
6.1.4 Integrating sphere measurements 
Tissue scattering and absorption coefficients (s and a, respectively) were determined 
using an integrating sphere (IS) and the inverse adding-doubling (IAD) method [83]. The 
adding-doubling method models random scattering events in a planar sample by 
approximating the sample as a discrete number of scattering layers and scattering angles. 
The IAD method used iteration to fit the measurements, and was implemented using IAD 
software available online [84]. The method required separate measurements of diffuse 
reflectance, diffuse transmittance, and collimated transmittance as illustrated in Figure 
6.3. A CW tungsten halogen lamp (LS-1, Ocean Optics) emitting light between 360-2000 
nm with a 200 micron fiber coupling was used for all measurements. 
Two cultured AC tissue samples, each with overall thickness 1.2 mm, were measured. 
For diffuse reflectance measurements, the light source was attached to the reflectance 
port (Port 3) of an integrating sphere (Avasphere-30, Avantes, Boulder, CO) (Figure 
6.3a). The sample was placed at the sample port (Port 1, 8 mm diameter) and the 
collimated light formed a spot size approximately 5 mm in diameter on the sample. The 
sum of intensity of diffuse and specular reflected light was measured using a 
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spectrometer (USB-2000, Ocean Optics) coupled to the IS with a 600 micron core fiber at 
the detection port (Port 2).  Integration times varied from 4-60 seconds. Reflectance 
measurements were calibrated using a 75% reflectance standard (SRS-75-010, 
Labsphere, North Sutton, New Hampshire).  
 
  
Figure 6.3 (a) Schematic for diffuse reflectance and transmittance measurements using an 
integrating sphere. (b) Schematic for collimated transmittance measurements.  (L- Lens; LP – 
long-pass filter; SP – short-pass filter; BP – band-pass filter; PMT – photomultiplier tube; Port 1 – 
sample port; Port 2 – detection port; Port 3 – reflectance port) [56]. 
 
Diffuse transmittance measurements (Figure 6.3a) were taken by collimating the fiber 
coupled light source by a lens pair (L1 and L2) to form a spot size approximately 4 mm 
in diameter at the sample.  For this measurement, the IS was tilted to prevent collimated 
transmitted light from falling on the uncoated portion of the sphere at the reflectance port. 
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wavelengths less than, and greater than 420 nm - by placing appropriate filters (SP or LP) 
in front of the lamp. This reduced the number of photons hitting the spectrograph detector 
and avoided saturation of the detector. 
For collimated transmittance measurements (Figure 6.3b) the IS and spectrometer were 
removed and a photomultiplier tube (PMT) (R928, Hamamatsu) was employed for light 
detection. A pinhole placed in front of the PMT limited the acceptance angle to 0.17 
degrees to eliminate fluorescent and diffuse light. An optical chopper (SR540, Stanford 
Research Systems) and lock-in amplifier (LIA-MV-150, Femto, Berlin, Germany) were 
employed to increase sensitivity. Measurements were taken for 9 wavelengths by placing 
narrowband (nominally 10 nm full width at half maximum) band-pass (BP) filters at the 
source (Table 6.1). Transmittance measurements were calibrated using ND filters of OD 
1.0 (03FNQ015, Melles Griot) and OD 3.0 (03FNQ027, Melles Griot).  
6.1.5 Monte Carlo model for photon migration simulations 
An MC transport code [16] was used to simulate both time-resolved reflectance and 
fluorescence from an AC tissue model (Figure 6.4). The AC tissue model was a bulk 
medium (0.12 cm thickness) containing two uniformly distributed fluorophores 
(intracellular NADH and collagen type II in the extracellular matrix). 2.5x107 photons 
were launched into the tissue model normal to the surface, at the air-tissue interface via a 
source optical fiber of specified numerical aperture (0.22) and diameter (600 microns 
core). Reflectance and fluorescence escaping the tissue per unit time was collected at 
surface within detector annuli concentric with the source fiber. The spacing between 
consecutive (detection) rings was identical and set equal to source fiber diameter. As 
described in Section 2.2, photon trajectories (black lines, Figure 6.4) were constructed by 
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stochastic sampling of scattering angles (specified by the anisotropy coefficient, g) and 
path lengths (specified by the scattering coefficient, s). Each photon entered the tissue 
medium with a weight of unity, which was attenuated exponentially as given by Beer’s 
law for the absorption coefficient a of the medium. After each scattering step, a new 
direction for the photon trajectory was calculated via the scattering phase function (the 
Henyey-Greenstein function [62]), which is specified by the anisotropy coefficient (g) of 
the tissue. The flight of the photon ended when it left the tissue (by crossing the tissue-air 
interface) or when its weight fell below a threshold minimum value (set to 1x10-5), as 
determined by a Russian roulette routine [62]. At the end of its travel in the tissue, the 
time, t, spent by the photon within the medium was given by t = L/nc, where L is the total 
path-length of the photon, c is the speed of light in vacuum, and n is the refractive index 
of the medium [63]. 
 
Figure 6.4 Model for articular cartilage tissue showing fluorescence from two uniformly 
distributed fluorophores (intracellular NADH and extracellular collagen) relative to the excitation-






























For the two-fluorophore AC tissue model studied here, the simulation supported tissue 
models containing Nf  = 2 fluorophores (emitting at Nf different wavelengths) that were 
considered to be uniformly distributed in the tissue medium [85]. The incident excitation 
could be absorbed by any one of the Nf fluorophores. After each scattering event of the 
excitation photon, fluorescence absorption was sampled using a rejection technique, as 
governed by a cumulative fluorescence absorption coefficient Maf. Here, Maf was the sum 
of the fluorescence absorption coefficients (afx) of all Nf fluorophores specified in the 
tissue model, i.e. Maf = iafx (1i Nf). Once it was determined that the photon had been 
absorbed to produce a fluorescence photon, the wavelength of the remitted fluorescence 
photon was selected by a MC routine, where the probability of absorption of the 
excitation photon by one of the Nf fluorophores was equal to the ratio 
iafx af (1i Nf) 
[85]. Upon successful fluorescence absorption, the excitation photon was relabeled a 
fluorescence photon, its new direction of travel was determined by an isotropic scattering 
event, and its weight was multiplied by the fluorescence quantum yield, iQY. This newly 
created fluorescence photon then continued to propagate from the point of its spatial 
origin (blue lines - collagen type II, red lines – NADH in Figure 6.4), as governed by the 
scattering, absorption, and anisotropy coefficients of the medium at the fluorescence 
emission wavelength. After each successful fluorescence absorption event, the simulation 
added a sampled decay time, td, to the photon's total time of flight to include the effect of 
a finite fluorophore lifetime (τ0). 
To simulate the experimental procedure of placing the fiber probe above the AC sample 
surface, the reflectance and fluorescence photons were collected within an annulus of 
inner radius = 0.15 cm and outer radius = 0.33 cm (relative to source fiber center). The 
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simulation required input values of a and s, which were obtained from IS experimental 
measurements while the anisotropy was kept at a literature value of g = 0.9 [86], as 
described in Section 6.1.6.2. In this study, separate codes were run for two fluorescence 
emission wavelengths (400 nm and 540 nm) to simulate experimental data. Wavelength 
dependence of fluorescence emission characteristics of the two fluorophores were 
introduced by using the spectrally weighted fluorescence emission W(λ) described in 
Section 6.1.3 in lieu of the quantum yield coefficients iQY. The tissue thickness z1 was 
the same as those for the samples used in Section 6.1.4. Fluorophore lifetime for bound 
NADH was set to 1.5 ns [11, 36]. The input values for the fluorescence lifetime of 
collagen and the relative fluorophore absorption coefficients iafx (for collagen and 
NADH) were matched to simulate experimental measurements (described in Section 
6.1.6.4). 
Table 6.1. Scattering and absorption coefficients for AC tissue  (g = 0.9) 
Wavelength (nm) μa (cm
-1) μs (cm
-1) 
400 0.50 ± 0.05 300 ± 75 
420 0.56 ± 0.02 285 ± 57 
460 0.45 ± 0.16 220 ± 61 
480 0.47 ± 0.09 188 ± 48 
500 0.44 ± 0.23 168 ± 46 
520 0.65 ± 0.06 133 ± 67 
540 0.46 ± 0.21 199 ± 32 
560 0.49 ± 0.21 125 ± 27 
600 0.50 ± 0.20 106 ± 20 
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6.1.6 Results and discussion 
6.1.6.1 Fluorescence excitation-emission matrix (EEM) 
Figure 6.5a shows EEM data for AC tissue sample #12 (Table 6.2). The EEM 
fluorescence intensity pattern was consistent with endogenous tissue fluorescence from 
extracellular collagen and intracellular NADH [5, 8-10, 25, 54, 55]. Figure 6.5b shows 
this EEM data around excitation wavelength 355 nm, which was the wavelength 
employed for excitation in RFLS studies. These EEM tissue data were consistent with 
measurements on pure collagen and NADH at 355 nm excitation (Figure 6.2), further 
confirming the hypothesis that these two fluorophores represent the primary components 
of AC tissue autofluorescence in RFLS studies. Thus, the AC tissue model developed for 
computational simulations of these measurements was composed of these two 




Figure 6.5 (a) Measured EEM of articular cartilage (AC) tissue showing fluorescence emission 
primarily associated with extracellular collagen and intracellular NADH [56]. (b) Same EEM 
expanded to highlight the area between white dotted lines in (a) [56]. RFLS excitation occurred at 
355 nm. The EEM data was measured on the Fluorolog-3 spectrofluorometer. 
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6.1.6.2 Porcine AC tissue optical coefficients 
AC Tissue optical absorption (μa) and scattering (μs) coefficients at nine wavelengths 
were calculated from IS measurements by employing the IAD software and an anisotropy 
value of g = 0.9 [86] (Table 6.1). For each coefficient, the table lists the mean ± standard 
deviation over data obtained on two AC tissue samples. The μs values decreased with 
increasing wavelength indicating lower wavelengths were scattered more by the tissue. 
There was no such specific trend for μa values. MC simulations were run using the two 
sets of μa and μs that were calculated using data from both tissue samples. 
6.1.6.3  Reflectance spectroscopy: experimental measurements and 
computational modeling 
 
Figure 6.6 Average, measured (gray, solid line) and simulated (black, triangles) normalized 
reflectance spectra from porcine AC [56]. The normalization was done by setting reflectance at 
540 nm to unity. The model inputs at each indicated wavelength were obtained from integrating 
sphere measurements. The error bars represent the results of the variations in the optical properties 
(see Table 6.1) input to produce the simulations. 
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 Reflectance from 11 AC tissue samples (samples # 1-11, Table 6.2) varied over the 
wavelength spectrum and increased between 400 nm and 540 nm. The gray line in Figure 
6.6 shows the measured average normalized reflectance as a function of wavelength 
between 400 and 600 nm. The normalization procedure set the reflectance at 540 nm to 
unity. Table 6.2 lists details of sample preparation for all samples, as well as the 
percentage increase (ΔR), in reflectance at 540 nm (R540) vs. reflectance at 400 nm (R400). 
Thus, ΔR = [R540 - R400]*100/ (R540). The average measured ΔR value was found to be 23 
(±7) %. 
 








fluorescence decay time 
(ns) 
BP! 400 nm      BP 540 nm
Simulated 
fluorescence 
decay time (ns) 
at BP 540 nm 
Extracted 
η% 
1 Freshly harvested 25 % 4.3 4.0 4.04 25.00
2 Freshly harvested 17 % 5.4 5.3 5.25 60.00
3 Freshly harvested 29 % 4.8 4.1 4.13 12.00
4 Freshly harvested 22 % 4.9 4.1 4.13 10.54
5 Freshly harvested 11 % 5.1 4.5 4.49 15.00
6 Cultured* 28 % 5.4 4.0 3.98 5.45
7 Cultured* 28 % 5.3 4.8 4.81 20.33
8 Cultured 22 % 5.2 4.6 4.60 16.00
9 Cultured 13 % 5.1 4.0 4.00 7.00
10 Cultured 29 % 5.1 4.6 4.59 18.53
11 Cultured 27 % 5.2 4.4 4.42 11.50
12 Freshly harvested - 5.2 4.2 4.21 8.52
13 Freshly harvested - 5.3 4.2 4.21 7.59
14 Cultured - 6.4 3.0 3.00 1.38
15 Freshly harvested - 5.1 4.5 4.49 15.00
 Average value 23± 7 % 5.2 ±0.4 4.3±0.5  
* Measurements taken on different sites of an elongated tissue sample. 
$ ΔR =  percentage increase in reflectance at 540 nm (R540) vs. reflectance at 400 nm (R400) 
! BP = band-pass filter 




A set of nine simulations were run to study the radially resolved reflectance at nine 
excitation wavelengths between 400-600 nm (listed in Table 6.1). At each wavelength, 
two simulations were run using two sets of μa and μs values, obtained as described in 
Section 6.1.6.2. Figure 6.6 shows mean normalized reflectance (black triangles) 
calculated by the MC simulations. The error bars represent the standard deviation 
between outcomes at each wavelength. The MC simulation predictions matched well with 
the average experimental data over the entire spectral range with a maximum residual 
error of 11% and predicted a R of 15 (±2) %. This corroboration between experiment 
and simulation for reflectance gave us confidence in our estimation of the wavelength 
dependence of the tissue optical properties of porcine AC. A similar study has been done 
to assess bovine cartilage thickness using MC simulations [87]. This study did not 
consider any wavelength dependence of the absorption and scattering coefficients. 
6.1.6.4 Fluorescence and fluorescence lifetime spectroscopy: 
experimental measurements and computational modeling 
Figure 6.7a shows a representative normalized intrinsic fluorescence spectrum from 
(sample # 15, Table 6.2) porcine knee AC tissue measured using the RFLS (black line). 
The fluorescence emission peaked near 400 nm, and was attributed to collagen dominated 
emission. The measured average decay time for the entire spectrum (i.e. with no BP filter 
employed) was observed  to be 5.4 ± 0.5 ns, which was consistent with collagen 
dominated emission [88]. Figure 6.7a also shows the band-pass filters centered at 400 nm 
(dashed blue box) and at 540 nm (dashed red box), employed to take time-resolved 
measurements as described in Section 6.1.3. These representative, normalized time-
 91
resolved data obtained from the same AC tissue (sample # 15, Table 6.2) are shown in 
Figure 6.7b for the BP at 400 nm (solid blue line) and for BP at 540 nm (dashed red line).  
 
Figure 6.7 (a) Autofluorescence spectrum of AC tissue (black line) acquired on the RFLS. Blue 
and red boxes indicate band-pass (BP) filters placed at 400 and 540 nm to measure fluorescence 
decay times for photons from those parts of the spectrum [56]. (b) Time-resolved fluorescence of 
the tissue with a BP filter of 400 nm (solid blue line) and a BP filter of 540 nm (dashed red line). 
The black dotted line shows the excitation pulse temporal profile (instrument response) [56]. 
 
The dotted black line in Figure 6.7b shows the temporal profile of the excitation laser 
pulse. As can be seen in Figure 6.7b, the blue curve (BP 400) decayed slower than the red 
curve (BP 540). This trend was seen consistently amongst all the 15 measured samples 
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(Table 6.2). A one sided, unequal variances, Student t-test for the mean values of decay 
time at 400 nm and 540 nm wavelengths, yielded a P-value of 1.21x10-5, indicating that 
the mean decay times were different from each other at the two band-pass filter locations. 
As mentioned earlier, collagen type II and NADH were considered to be the two major 
fluorophores in the porcine AC tissue sample. The time-resolved fluorescence decays 
from each AC tissue sample at the two emission wavelengths (with BP filters centered at 
400 nm and 540 nm) were simulated via two different tissue models to account for the 
differences in the optical transport coefficients at these two wavelengths. These simulated 
decays were analyzed by a bi-exponential model and an average decay time parameter 
was determined [36].  
For each tissue model the tissue optical transport coefficients required at the central 
wavelength of each BP were obtained from the IS measurements as discussed in Section 
6.1.6.2 (Table 6.1). The spectrally weighted fluorescence emission W(λ) (Figure 6.2) at 
the corresponding central wavelength of the BP filter were used in lieu of the fluorophore 
quantum yields. These spectrally weighted fluorescence emission coefficients were 
1.35x10-3 and 1.35x10-5, for collagen and NADH, respectively, for the 400 nm BP tissue 
model while at 540 nm they were 8.64x10-5 and 2.80x10-4 for collagen and NADH, 
respectively. 
Given these inputs for the fluorophore quantum yield coefficients, the simulations 
predicted that average decay time for the fluorescence signal at 400 nm using the bi-
exponential model collapsed to the original input lifetime of collagen in the tissue model 
(irrespective of the exact values of the lifetimes of either fluorophore), if () the ratio of 
the fluorophore absorption coefficient of collagen to that of NADH was greater than 0.1, 
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which included the most physically plausible values for these fluorophores [36]. This 
behavior was anticipated in these simulations, since the weight of remitted fluorescence 
photons from collagen was on average 100 (approximately the ratio of the W(λ) inputs of 
collagen to NADH at 400 nm) times larger than weight of remitted fluorescence photons 
from NADH. This result, however, meant, that each measured average decay time with 
the 400 nm BP filter would have to be interpreted as the lifetime of collagen for each 
particular sample. The variability seen amongst samples could be attributed to changes in 
the environment of the fluorophore.  
Hence, in the 540 BP tissue model, for each sample, the input lifetime of collagen was set 
to the average decay time measured (for the same sample) via the 400 nm BP while 
holding the lifetime of NADH at 1.5 ns. The model was then used to extract the 
fluorescence absorption coefficients (afx) of both fluorophores by matching (to within 
1%) the simulated average decay time at 540 nm to the experimentally measured 
fluorescence decay time measured via the 540 nm BP. Table 6.2 shows the values for 
the ratio of the fluorescence absorption coefficient of collagen to that of NADH for 
each measured AC tissue sample. Also shown are the predicted values of the simulated 
decay times using the  values specified. The extracted  values were found to vary by a 
large amount. One source of this variation could be the high variability in biological 
samples which can not be accounted for by simulations. It is thought that by repeating 
this study for a large number of samples the expected range of  values for naturally 
occurring AC tissues could be extracted. Then comparison of  values for artificially 
constructed AC tissue with this range could serve as a check of the viability of the 
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construct. In addition, this method of extracting  values could be used to monitor the 
development of an AC tissue construct over time, in a non-invasive manner. 
Previous fluorescence lifetime imaging studies of what appear to be fixed and sectioned 
slices of porcine AC did not explain the biological origins of the detected fluorescence 
nor the statistical significance of the obtained data [89]. 
6.1.7 Summary and conclusions 
In conclusion, a method for noninvasive, quantitative characterization of fresh tissues 
using reflectance and fluorescence measurements was applied to porcine knee AC. To the 
best of our knowledge, the work described in this report is the first study of endogenous 
fluorescence from unfixed and untreated porcine knee AC, where the biological origins 
of the measured fluorescence and reflectance are explained in the context of a 
quantitative model for photon transport in AC tissue.  
MC simulations of photon propagation in a single layer, two – fluorophore (extracellular 
collagen type II and cellular NADH) tissue model were used to quantitatively explain 
experimentally measured fluorescence and reflectance signals from AC tissue. The 
concept of a spectrally weighted fluorescence emission W(λ) was introduced to account 
for the wavelength dependence of fluorescence emission characteristics of the two 
fluorophores. The experimental and computational results agreed to within 11% of the 
mean reflectance spectra (from 11 samples), which provided the wavelength dependent 
tissue optical properties (μa and μs) for porcine AC tissue models. For fluorescence 
measurements, a combination of experimental measurements and computational 
simulation was used to extract a quantitative description of the samples. For each AC 
tissue sample, the MC simulations for fluorescence used the measured decay time at BP 
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400 nm as an input to extract the ratio of fluorescence absorption coefficients () of the 
constituent fluorophores such that simulated average decay time at 540 nm were made to 
match to within 1%, the experimentally measured fluorescence decay time.  
Although the AC tissue models used the optical transport coefficients determined via the 
IS-estimated average, it is to be noted that the reflectance spectrum from each sample 
could be inverted via MC simulations (guided by the IS values) to obtain the sample’s 
transport coefficients. Estimation of μa and μs using MC simulations vs. IS, for tissue 
models that had identical η values but modeled extreme variations of the transport 
coefficients, yielded average decay times (at 540 nm) that were within 1% of the decay 
time determined via using the IS estimates. 
The approach presented here attributes a single fluorescence decay time to each 
constituent fluorophore in a tissue. A further refinement to this approach could include 
changes in fluorophore lifetime with emission wavelength. Although future systematic 
studies on pure substances should resolve conflicting reports existing in the literature 
regarding lifetime variations with wavelength (for example, for collagen [88]), it remains 
problematic to use data acquired on pure substances to describe those molecules in 
complex environments, such as biological tissues.  An alternate and more biologically 
relevant approach would be to employ optical molecular imaging (via, e.g., fluorescence 
lifetime imaging microscopy) to characterize spatially-resolved endogenous fluorophores 
in their tissue environment.  These studies are ongoing and should prove useful to 
enhance the ability to quantitatively interpret experimental measurements on tissues. 
Hyaline AC is found in the synovial joints and is an important contributor to the 
functional capacities of these joints. If a chondral defect or lesion occurs, it does not heal 
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on its own. Thus methods are being developed to make tissue constructs that would 
mimic true AC. Pre- and post implantation testing of the viability of these constructs can 
potentially be done by analyzing the optical signal from them. Towards this goal, a first 
step has been taken to optically characterize porcine knee AC. This work and the 
methods developed here should aid in the future study of AC tissue constructs. For 
example, monitoring the change in  value for a sample over time would help detect 
changes in the sample’s biological make-up by giving a measure of changes in relative 
concentrations of the constituent fluorophores. Furthermore, since the method would be 
non-destructive, it would allow repeated assessment of a given sample over time to 
follow intervention, thereby significantly speeding up lengthy and expensive protocols 
requiring multiple samples. 
6.2  Oral mucosa constructs 
6.2.1 Engineering oral mucosa constructs 
Ex vivo produced oral mucosa equivalent (EVPOME) constructs are manufactured by 
seeding human oral keratinocytes onto an acellular dermal matrix namely, AlloDerm® 
(LifeCell, Branchburg, NJ, USA). AlloDerm is non-immunogenic human cadaver skin 
from which the cellular component has been removed to leave a matrix composed mainly 
of collagen. Details of the EVPOME manufacturing process can be found in [43, 46, 90]. 
Briefly, the dry AlloDerm® is first cut into a 1 cm diameter circle and immersed thrice in 
phosphate buffer saline (PBS) solution for 30 minutes to re-hydrate the dermal matrix 
and to remove any antibiotics injected to preserve the matrix. The re-hydrated 
AlloDerm® is then immersed overnight in a solution of PBS and collagen-IV to enhance 
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the attachment of keratinocytes. The harvested keratinocytes are then seeded on to the 
AlloDerm® on what is referred to as day 0 of the manufacturing process. The 
keratinocytes and AlloDerm® composite is then cultured submerged in cell culture media 
for four days. On day 4, the composite is raised to the air-liquid interface with an increase 
in calcium concentration to encourage stratification and is cultured in this manner until 
day 11. By this stage, the cell-matrix composite has undergone keratinocyte 
differentiation and stratification with formation of a keratinized layer, and the EVPOME 
construct is ready for implantation. Figure 6.8 shows the histology of a typical day 11 
EVPOME construct consisting of keratin (layer 1), keratinocytes (layer 2), and 
AlloDerm® scaffold (layer 3). 
 
Figure 6.8 Cross-sectional histology of a day 11 EVPOME construct showing the three 
layers of the construct – keratinized layer, keratinocytes and AlloDerm® scaffold. 
 
 
6.2.2 Optical signatures in EVPOME constructs 
In order to investigate the sources of fluorescence in the cellular layer of EVPOME 






employing the spectrofluorometer Fluorolog-3 (described in Section 4.1.3) at 355 nm 
excitation which is the excitation wavelength of the RFLS.  
 
Figure 6.9. Plot of normalized fluorescence intensity measured from oral keratinocytes at 
355 nm excitation. The data was measured on the Fluorolog-3 spectrofluorometer. 
 
 
Figure 6.9 plots the normalized fluorescence intensity measured from oral keratinocytes. 
The observed fluorescence peaks were associated with NAD(P)H and FAD fluorescence 
[9]. As stated in Section 6.2.1, AlloDerm® is composed mainly of collagen. The 
constituent fluorophores in a day 11 EVPOME could thus be assumed to be the acellular 
keratin in the first layer, NAD(P)H and FAD in the second layer where the oral 
keratinocyte cells reside, and collagen in the third layer. Hence, it could be conjectured 
that assessment of the biological viability of the EVPOME constructs should be 
achievable by using fluorescence spectroscopy to target the fluorophores in the cellular 
component of the EVPOME namely, NAD(P)H and FAD. Previous studies done by us on 




















































indicated that cell size correlates positively with flavoprotein autofluorescence intensity 
[91]. The stem cell population has been found to reside in the small cell population while 
more mature differentiated cells are larger in size [92]. Thus, we expect the fluorescence 
intensity owing to FAD to increase as the cells mature and become larger in size i.e. as 
the EVPOME graft goes through its manufacturing process, with an increase in cell 
stratification. This provides a possible tool for sensing changes (hence viability), non-
invasively, in the cellular component of EVPOME from day 0 to day 11 of the 
manufacturing process. 
The cells in an EVPOME construct are present in a relatively thin layer buried between 
highly scattering and fluorescent keratin and collagen layers (Figure 6.8). This poses a 
significant challenge to the measurement of cellular autofluorescence. In the remaining 
text, we describe the Monte Carlo (MC) simulations and experiments executed to 
optimize detection of cellular autofluorescence in EVPOME constructs. Fluorescence 
simulations and measurements were executed for a 355 nm excitation wavelength 
(preferential excitation of NAD(P)H) and simulations were also implemented at 450 nm 
excitation wavelength (preferential excitation of FAD) for different optical probe designs 
to arrive at an optimum experimental set up for cellular autofluorescence detection.  
6.2.3 Monte Carlo simulation of photon transport in EVPOME 
constructs at 355 nm and 450 nm excitation 
A previously validated multi-fluorophore, multi-layer MC code of light propagation in 
tissue [15, 56, 61] was employed to simulate fluorescence in a day 11 EVPOME 
construct model. The EVPOME construct model was considered to be a three layer 
model with the fluorophore keratin in acellular layer 1, cells with NAD(P)H and FAD in 
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layer 2, and collagen in layer 3 (Figure 6.10). Simulations were executed at 355 nm and 
450 nm excitation to predict (as a function of source detector fiber separation) the 
contributions to the detected fluorescence, from the fluorophores in different layers of the 
EVPOME. The simulations at 355 nm excitation were executed with optical fiber 
diameters of 100 µm. Simulations at 450 nm were executed for two optical fiber 
diameters, 50 µm and 100 µm. The tissue optical properties and fluorophore optical 
properties required as inputs to the MC codes are described in Section 6.2.4.  
 
Figure 6.10 Schematic of the layers in an EVPOME construct on day 11 of the 
manufacturing process. Modeling was done for excitation wavelengths 355 nm and 450 
nm assuming keratin (acellular), NAD(P)H and FAD in cells, and collagen to be the 
fluorophores localized in the layers as shown in the figure.  
 
For each simulation, excitation photons were launched from a source fiber normal to the 
tissue surface. The photons per unit time exiting the tissue surface were collected by 
annuli of detectors placed around the source fiber at radii increasing in steps equal to the 
source fiber diameter. Photons entered the tissue with a weight of unity which was 
attenuated as governed by the absorption coefficient (a) of the medium. The trajectory 
Source Fiber Detector Fiber
Layer 1 Acellular KERATIN (10 microns)
Layer 2 Cells with NAD(P)H and FAD 
(50 microns)
Layer 3 COLLAGEN (500 microns)
ρ
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of the photon in the medium was based on the scattering coefficient (s) and anisotropy 
coefficient (g) of the medium. The different layers of the tissue were represented by a 
change in tissue optical properties (a, s, and g) and the path of the photons as they 
traversed between layers was governed by the Snell’s laws and any refractive index (n) 
mismatch. The flight of the photon ended when it left the tissue (by crossing  the tissue-
air interface) or when its weight fell below a threshold minimum value (set to 1x10-5), as 
determined by a Russian roulette routine [62].  
In any layer, the absorption of the excitation photon by a fluorophore was governed by 
the sum of the fluorophore absorption coefficients (μafx) of all fluorophores (Nf in 
number; = 1, 2, and 1 for layers 1, 2, and 3 respectively) in that layer. Where, each 
fluorophore was assumed to emit at a distinct emission wavelength (m).  The probability 
that the ith fluorophore (1 ≤ i ≤ Nf) in a layer absorbed the excitation photon was equal to 
the ratio iμafx / Σ
iμafx (1 ≤ i ≤ Nf). Once absorbed by the i
th fluorophore in a layer, the 
excitation photon was marked as a fluorescence photon having wavelength im and was 
scattered isotropically. The weight of the photon was scaled by the quantum yield (i) of 
that fluorophore and the trajectory was now governed by the scattering, absorption, and 
anisotropy coefficients of the medium at the fluorescence emission wavelength. The code 
kept an account of fluorescence weight per unit time of photons exiting the tissue surface 
at all emission wavelengths. These weights were integrated over time to give the steady 
state fluorescence detected at each detector due to each fluorophore. 
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6.2.4 Inputs to the Monte Carlo codes  
In order to implement the MC simulations, it was necessary to specify the thickness and 
refractive index of each layer, tissue optical properties (a(), s(), and g)  of each of the 
excitation (x) and emission wavelengths (m) in each layer, and the fluorophore optical 
properties (afx , , and ) for all the fluorophores. 
Tissue optical properties of EVPOME 
The thickness of the layers were set to be 10 m, 50 m, and 500 m, to model a typical 
day 11 EVPOME (shown in Figure 6.10). The refractive index was set to 1.4 for all 
layers and the anisotropy (g) was set to 0.9, 0.85, 0.7 for layers, 1, 2, and 3, respectively 
[81]. Table 6.3 and Table 6.4 list the absorption (µa) and scattering coefficients (µs) used 
for simulations at 355 nm and 450 nm excitation, respectively. These were obtained from 
an algorithm [93] for extracting µa(λ) and µs(λ) for layers in skin, but with blood content 
set to zero.  
 
Table 6.3. Tissue absorption(a) & scattering coefficients(s) used for MC 
simulations at an excitation wavelength of 355 nm [80]. 
 (Fluorophore) 
(nm) 













355 ( Excitation)   3.88   
420 (Keratin)   2.27   
450 ( NADH)   1.81   
530 ( FAD)   1.06   
430 ( Collagen)   2.1   
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Table 6.4. Tissue absorption(a) & scattering coefficients(s) used for MC 
simulations at an excitation wavelength of 450 nm 
 (Fluorophore) 
(nm) 













450 ( Excitation) 3.17 577   1.81 385 
520 (Keratin) 1.95 499   1.13 333 
525 ( NADH) 1.87 494   1.09 329 
530 ( FAD) 1.83 490   1.06 327 
 500 (Collagen) 2.22 519   1.28 346 
 
Fluorophore optical properties of EVPOME 
The fluorophore optical properties employed for the MC codes at 355 nm and 450 nm 
excitation are shown in Table 6.5. These values were chosen based on literature as well 
as experiments performed by us (described below).  
 
Table 6.5. Fluorophore properties used for Monte Carlo simulations of light  
propagation in EVPOME constructs at 355(450)  nm excitation. 

 
Keratin NAD(P)H FAD Collagen 
Emission 
(nm) 
420 (520) 450 (525) 530 (530) 430 (500) 
Decay Time 
(ns) 
4.0 (4.0) 1.5 (1.5) 3.0 (3.0) 5.0 (5.0) 
Quantum 
Yield 
0.25 (0.01) 0.05 (0.005) 0.03 (0.03) 0.4 (0.04) 
afx  (cm-1) 0.5 (0.5) 0.6 (0.01) 0.9 (1.6) 0.9 (0.9) 
 
The decay times of the fluorophores were assumed independent of the emission and 
excitation wavelengths. The values for keratin and FAD were obtained from [94] while 
for NADH and collagen were obtained from [36].  
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Fluorophore absorption coefficients and emission wavelengths for keratin were obtained 
from literature [95, 96]. The peak emission wavelengths and intensities at an excitation of 
355 nm and 450 nm for NADH, FAD and collagen were measured on a 
spectrofluorometer (SPEX® FL3-22 Fluorolog-3, Jobin-Yvon Horiba, Japan). Solutions 
of 0.005 mg/ml of NADH (N-8129, Sigma Aldrich, St. Louis, Missouri) in water, 0.06 
mg/ml of FAD (F6625, Sigma Aldrich) in water, and 1mg/ml of collagen (C5483, Sigma 
Aldrich) in acetic acid were used for the measurements. The absorbance of the same 
NADH, FAD, and collagen solutions were measured at the two excitation wavelengths 
using a spectrophotometer (DU® 800, Beckman Coulter, Inc., Fullerton, CA). The 
fluorophore absorption coefficients were then derived from the measured absorbance 
using the Beer-Lambert Law. 
The quantum yields () at 355 nm and 450 nm excitation were obtained from literature 
for keratin and FAD [81, 95, 97]. The values at 355 nm excitation for NADH and 
collagen were also obtained from literature [36]. In order to obtain an estimate of any 
order of magnitude change in the quantum yield of collagen and NADH at 450 nm 
excitation we considered the equation for calculation of quantum yield of an unknown 
sample [11] 


















      - 6.1  
Where, I denotes the integrated intensity, n denotes the refractive index, and A denotes 
the absorbance of the fluorophore at x excitation wavelength. The subscript R refers to 
reference fluorophore of known quantum yield and R was considered independent of the 
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excitation wavelength. A 1 M solution of Rhodamine 6G (83697, Sigma Aldrich) in 
ethanol was employed as the reference fluorophore [11].   
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     - 6.4 
Measured integrated emission intensity and absorbance at the 355 nm and 450 nm 
excitation for both collagen and NADH indicated order of magnitude ratios of quantum 



















   - 6.5 
Estimates for quantum yields of NADH and collagen at 450 nm excitation were thus 
obtained by scaling the quantum yield values at 355 nm excitation (Table 6.5) by a factor 
of 10. 
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6.2.5 Steady-state fluorescence measurements at 355 nm excitation 
A portable, fiber-optic coupled Reflectance and Fluorescence Lifetime Spectrometer 
(RFLS) (described in Chapter 3) was employed for steady-state fluorescence spectra 
measurements from a day 11 EVPOME and from an acellular AlloDerm® kept under 
similar conditions, as a control. Prior to data acquisition, the EVPOME and Alloderm® 
were dipped in PBS to wash away any cell culture media. The excitation light was 
delivered to the sample via a source optical fiber of 100 µm diameter and the emitted 
fluorescence was collected via a separate 100µm diameter collection fiber placed 
adjacent to the source fiber at the distal end (same fiber probe configuration as in the MC 
simulations at 355 nm excitation). For each spectrum, a background spectrum was 
acquired with the source blocked and was subtracted from the detected sample spectrum. 
Background subtracted data were then corrected for the spectral instrument response of 
the RFLS. The calibrated spectra were then normalized by scaling the peak intensity to 
unity. Details of these calibration procedures are described in Chapter 3. 
6.2.6 Results of the MC simulations and experiment 
Figure 6.11 shows the simulated fractional contributions from layers 1, 2, and 3 (black 
squares, red circles, and blue triangles, respectively) of a day 11 EVPOME to the 
detected fluorescence signal at 355 nm excitation as a function of source-detector 
separations (ρ). The simulations indicated that detected signal would be dominated by 
fluorescence from layer 3 i.e. collagen, at all ρ, thus making it difficult to assess changes 
occurring in layer 2 where the cells reside. Thus, while 355 nm excitation would 
preferentially excite NAD(P)H in the cells, collagen would emit at a much higher 
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quantum yield. As a result, that fluorescence collected at the tissue surface would be 
dominated by collagen emission. 
 
Figure 6.11. Results of MC simulations executed for day 11 EVPOME Model - Plot of simulated 
fractional contributions to the detected fluorescence signal from layer 1 (keratin : black squares), 
layer 2 (NADH+FAD :  red circles), and layer 3 (Collagen  : blue triangles) of a Day 11 EVPOME 
construct at 355 nm excitation for different source-detector separations. The green dashed line 




Figure 6.12 shows the measured normalized fluorescence intensity (normalized by setting 
the peak intensity to unity) from AlloDerm® (blue dashed line) and EVPOME (red solid 
line) on day 11 at 355 nm excitation. The source detector separation was 100 microns 
(green dashed line in Figure 6.11). The measured signal from EVPOME could be 
associated predominantly with fluorescence from AlloDerm® alone (Layer 3). This 
confirmed the simulated results at 355 nm excitation.  The variation in the measured 
spectra was within the variation seen among measured spectra from different batches of 
AlloDerm® tested. 
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Figure 6.12. Plot of the measured normalized steady-state fluorescence from an EVPOME 
construct on Day 11 (red line), and from AlloDerm® kept under similar conditions (blue dashed 
line). Measurements were made at 355 nm excitation employing the Reflectance and Fluorescence 
Lifetime Spectrometer (RFLS); source and detector fiber diameters were 100 µm for simulations 
and experiment (dashed green line in Figure 6.11). 
 
Figure 6.13 shows results of MC simulations at 450 nm excitation for two fiber diameters 
100 µm (Figure 6.13a) and 50 µm (Figure 6.13b). The results indicated that employing 
450 nm excitation and ρ = 0 would preferentially excite the FAD in the cells while 
decreasing the emission from collagen in layer 3. However, while the relative 
contribution form cellular autofluorescence would be increased, the emission from layer 
3 would still be quite dominant. 
Comparing different fiber sizes indicated better extraction of cellular signal for the 
smaller (50 µm) diameter fibers.  However, as the fiber probe diameter is decreased, 
while the relative contribution of the cellular layer to the detected fluorescence could be 
increased, the over-all signal strength would decrease.  
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Figure 6.13. The simulated fractional contribution from Layer 1 (Keratin – black circles), Layer 2 
(NAD(P)H + FAD – red squares), and Layer 3 (Collagen – blue triangles) to the detected 
fluorescence at 450 nm excitation for different source-detector separations. Simulations were run 
with fiber diameters set to 100 µm (a) and 50 µm (b). 
 
6.2.7 Conclusion and discussion 
In conclusion, Monte Carlo simulations and fluorescence experiments were employed to 
optimize non-invasive characterization of cell viability in tissue engineered oral mucosa 
constructs. Monte Carlo simulations were executed to simulate fluorescence of day 11 
EVPOME constructs due to 355 nm and 450 nm excitations.  
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Fluorescence spectra measured at 355 nm excitation from day 11 AlloDerm® and 
EVPOME constructs validated the predictions of the simulations at 355 nm excitation. 
Both simulations and experiment indicated that the measured fluorescence signal from 
EVPOME constructs could be associated predominantly with fluorescence from 
AlloDerm® alone (layer 3) at 355 nm excitation. 
The simulations at 450 nm indicated that the relative fluorescence contribution from the 
cellular component of the engineered construct could be increased by employing 450 nm 
excitation light and a single fiber geometry for light delivery and detection. However, 
while the relative contribution to the detected signal from cellular autofluorescence 
would be increased, the emission from collagen in layer 3 would still be quite dominant. 
Simulations implemented at different fiber diameters showed a further increase in relative 
contribution from cellular autofluorescence with decrease in fiber diameters. However, 
while employing a 450 nm excitation wavelength and decreasing the size of the fibers 
would amplify the relative contribution to detected fluorescence from the cellular layer, 
the reduction in over all signal intensity would be a limiting factor.  
Thus, the results of this study indicate the need to investigate alternative solutions 
including different fiber probe geometries that might decrease collagen contribution 
while at the same time maximize fluorescence from the cellular layer in EVPOME. 
Angled fiber probes have been shown to be useful at selective excitation and collection of 
fluorescence from select areas of tissue samples [98]. Preliminary studies undertaken by 
us using MC codes at varying angles between source and detector fibers have shown 
promise at improving selective cellular fluorescence excitation and detection [99]. 
Another potential solution would be the use of fiber-optic coupled confocal microscopy 
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for selectively studying cellular autofluorescence. Chapter 7 shows preliminary 
measurements obtained from EVPOME constructs by employing confocal microscopy. 
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Chapter 7                                                             
Conclusions and Future Directions 
7.1  Summary and conclusions 
The primary goal of this dissertation was to develop and employ optical spectroscopic 
techniques for non-invasive sensing of (a) human pancreatic tissues to detect pancreatic 
adenocarcinoma and (b) engineered tissue constructs to assess the viability of the 
constructs during their manufacturing process.  
 
Chapter 3 discussed the design of a clinically compatible reflectance and fluorescence 
lifetime spectrometer (RFLS) developed as a part of this dissertation work. The RFLS is 
a portable, fiber-optic coupled instrument capable of measuring reflectance and 
fluorescence spectra and time-resolved fluorescence decays. The instrument employs a 
pulsed 355 nm excitation laser for fluorescence excitation and a continuous wave lamp 
emitting between 360 to 2000 nm as the reflectance source. The detectors are optimized 
for optical detection in the 380 to 800 nm wavelength range.  
 
In Chapter 4, we investigated whether optical spectroscopy could potentially aid in the 
detection of human pancreatic adenocarcinoma. Reflectance and fluorescence 
spectroscopies including time-resolved fluorescence decays were employed for the first 
time to probe freshly excised human pancreatic tissues and in vivo human pancreatic 
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cancer xenografts in mice. A total of 96 fluorescence and 96 reflectance spectra were 
considered from 50 tissue sites (including human pancreatic adenocarcinoma, chronic 
pancreatitis (inflammation), and normal tissues) on 9 patients. Measured optical spectra 
and fluorescence decays were correlated with tissue morphological and biochemical 
properties. Good correspondence was observed between spectra from human 
adenocarcinoma tissues and cancer xenografts grown in mice. In human pancreatic 
tissues, measurements were associated predominantly with endogenous fluorophores 
NAD(P)H and collagen, as well as tissue optical properties, with larger relative collagen 
content detected in adenocarcinoma and chronic pancreatitis than normal. Reflectance 
data indicated that adenocarcinoma had higher reflectance in the 430 to 500 nm range 
compared to normal and chronic pancreatitis tissues. The measured spectral features and 
decay times correlated well with expected pathological differences in normal, chronic 
pancreatitis and adenocarcinoma tissue states. 
Thus, the ability of multi-modal optical spectroscopy to detect signals from pancreatic 
tissue was demonstrated by studying human pancreatic cancer xenografts in mice and 
freshly excised human pancreatic tumor tissue. 
 
In Chapter 5, we presented the development of the first algorithms for pancreatic tissue 
classification using data from optical spectroscopy and assessed their diagnostic 
accuracy. The developed approach would be compatible with minimally-invasive 
diagnostic procedures for early cancer detection in the pancreas. Two classification 
algorithms using linear discriminant analysis were developed to distinguish among 
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tissues and leave-one-out cross validation was employed to assess the algorithms’ 
performance.  
The SpARC (Spectral Areas and Ratios Classifier) algorithm employed a combination of 
reflectance and fluorescence data and had sensitivity, specificity, negative predictive 
value, and positive predictive value for correctly identifying adenocarcinoma of 85%, 
89%, 92%, and 80%, respectively. The performance of the SpARC algorithm for 
adenocarcinoma distinction from normal tissue and chronic pancreatitis was comparable 
to that of, and in some cases better than, the reported performance of EUS-FNA [30], the 
currently accepted diagnostic standard. In the setting of pancreatitis, i.e. when the patient 
has adenocarcinoma and chronic pancreatitis, the sensitivity of SpARC (85%) was well 
above that of EUS-FNA (54%) [31] for distinguishing adenocarcinoma from chronic 
pancreatitis, which is an unmet clinical need in pancreatic cancer detection. Although the 
SpARC algorithm is simple to implement, its performance may be limited because it 
utilizes information at select wavelengths only. Towards this end, a chemometric 
algorithm employing principal component analysis (PCA) and linear discriminant 
analysis of fluorescence and reflectance spectra was developed for pancreatic tissue 
classification.  
The PCA algorithm that employed a combination of both reflectance and fluorescence 
classification variables performed the best and a maximum sensitivity, specificity, NPV, 
and PPV for correctly identifying pancreatic adenocarcinoma of 91%, 90%, 95%, and 
83%, respectively, was achieved. The algorithm’s performance was comparable and in 
some cases significantly better than that of EUS-FNA for pancreatic adenocarcinoma. 
Also, in the specimens where cancer was present along with chronic pancreatitis, the 
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sensitivity of the optical chemometric algorithm (82%) was well above that reported in 
other studies for  EUS-FNA (54%) for distinguishing between adenocarcinoma and 
chronic pancreatitis [31], indicating a significantly decreased likelihood of obtaining false 
negative results. PCA and LDA of a limited data set of chronic pancreatitis and normal 
tissue measurements indicated that inclusion of time-resolved fluorescence data in the 
analysis could improve the classification performance of the developed tissue 
classification algorithms.  
While the diagnostically relevant PCs cannot be linked to morphological or biochemical 
changes in tissue, PCA of the spectral data considers information at all wavelengths of 
the fluorescence and reflectance spectra. This is an improvement over the spectral areas 
and ratios classifier (SpARC) algorithm, which employed information only at select 
spectral wavelengths for tissue classification. The sensitivity for correctly identifying 
adenocarcinoma using the SpARC algorithm was 85% and is less than that of the optical 
chemometric algorithm developed in this study (91%). We are also developing a tissue 
classification algorithm that employs biophysical tissue parameters extracted from optical 
data using a photon-tissue interaction model we reported recently [72]. Future work will 
also involve data acquisition in vivo, with the aim of deploying the fiber-optic probe 
through a needle for optically-guided EUS-FNA. 
Thus, the developed tissue classification algorithms show promise for pancreatic tissue 
classification using multi-modal optical spectroscopy. In a clinical setting, such a 
classification procedure could be undertaken for rapid, automated tissue classification 
either to guide EUS-FNA procedures or to improve tumor margin detection during 
pancreatic surgery. 
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In Chapter 6, the prospect of employing developed optical spectroscopy instrumentation 
and previously developed Monet Carlo (MC) simulations to non-invasively and 
quantitatively investigate endogenous optical signals from tissue engineered devices was 
assessed. The methods developed have the significant advantage of being safe for clinical 
human use as they employed endogenous contrast.  
Porcine articular cartilage 
A method to non-invasively and quantitatively characterize thick biological tissues by 
combining both experimental and computational approaches in tissue optical 
spectroscopy was developed and validated on fifteen porcine articular cartilage (AC) 
tissue samples. To the best of our knowledge, this study is the first to couple non-invasive 
reflectance and fluorescence spectroscopic measurements on freshly harvested tissues 
with Monte Carlo computational modeling of time-resolved propagation of both 
excitation light and multi-fluorophore emission. The experimental and computational 
results agreed to within 11% of the mean reflectance spectra. Fluorescence data and 
simulations were used to extract the ratio of the absorption coefficients of constituent 
fluorophores for each measured AC tissue sample. This ratio could be used to monitor 
relative changes in concentration of the constituent fluorophores over time. The samples 
studied possessed the complexity and variability not found in artificial tissue-simulating 
phantoms and served as a model for future optical molecular sensing studies on tissue 
engineered AC constructs intended for use in human therapeutics. An optical technique 
that could non-invasively and quantitatively assess soft tissue composition or physiologic 
status would represent a significant advance in tissue engineering. Moreover, the general 
approach described here for optical characterization should be broadly applicable to 
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quantitative, non-invasive molecular sensing applications in complex, three-dimensional 
biological tissues. 
Oral mucosa constructs 
Monte Carlo simulations and fluorescence experiments were employed to optimize non-
invasive characterization of cell viability in tissue engineered oral mucosa constructs. 
Monte Carlo simulations were executed to simulate fluorescence of EVPOME constructs 
due to 355 nm and 450 nm excitation. Fluorescence spectra measured at 355 nm 
excitation from AlloDerm® and EVPOME constructs validated the predictions of the 
simulations at 355 nm excitation. Both simulations and experiment indicated that the 
measured signal from EVPOME could be associated predominantly with fluorescence 
from AlloDerm® alone (Layer 3) at 355 nm excitation. The simulations at 450 nm 
indicated that the relative fluorescence contribution from the cellular component of the 
engineered construct could be increased by employing 450 nm excitation light and a 
single fiber geometry for light delivery and detection. However, while the relative 
contribution to the detected signal from cellular autofluorescence would be increased, the 
emission from collagen in layer 3 would still be quite dominant. Simulations 
implemented at different fiber diameters showed a further increase in relative 
contribution from cellular autofluorescence with decrease in fiber diameters. However, 
while employing a 450 nm excitation wavelength and decreasing the size of the fibers 
would amplify the relative contribution to detected fluorescence from the cellular layer, 
the reduction in over all signal intensity would be a limiting factor. Thus, the results of 
this study indicated the need to investigate alternative solutions including different fiber 
probe geometries that might decrease extracellular contributions to the detected 
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fluorescence while at the same time maximize fluorescence detection from the cellular 
layer in EVPOME.  
 
The major contributions of this dissertation can be summarized as follows: 
 We designed and developed a clinically compatible, fiber optic coupled, reflectance 
and fluorescence lifetime spectrometer that could be employed for measuring 
reflectance and fluorescence spectra and time-resolved fluorescence decay curves 
from biological tissues. 
 We developed a graphical-user-interface for remote and fully automated detection of 
optical spectra in a clinical setting employing the RFLS. 
 We made the first in vivo and ex vivo measurements of reflectance and fluorescence 
spectra from human pancreatic xenografts in mice and correlated optical 
measurements with expected histopathology. 
 We made the first ex vivo measurements of reflectance and fluorescence spectra and 
time-resolved fluorescence decays from human pancreatic tissues resected during 
pancreatic surgeries.  
 We presented the first assessment of the diagnostic accuracy of algorithms developed 
for pancreatic tissue classification using data from optical spectroscopy by employing 
two tissue classification algorithms: the SpARC (Spectral Areas and Ratios 
Classifier) algorithm and the principal component analysis (PCA) algorithm. 
 We presented a novel method coupling non-invasive reflectance and fluorescence 
spectroscopic measurements on freshly harvested tissues with Monte Carlo 
computational modeling of time-resolved propagation of both excitation light and 
 119
multi-fluorophore emission and applied the developed methods to assess untreated, 
unfixed porcine articular cartilage using endogenous contrast. 
 We employed Monte Carlo simulations and fluorescence experiments for the first 
time to optimize the detection of cellular autofluorescence in ex vivo produced oral 
mucosa equivalent (EVPOME) constructs using endogenous contrast. 
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7.2  Future directions 
7.2.1 Changes to the RFLS instrumentation 
While certain changes to the spectrometer instrumentation including, laser excitation 
wavelength and fiber probe geometry, would depend on the biological system being 
studied, other changes can be made to improve the working of the RFLS. Some of these 
changes will be useful during data acquisition in an in vivo setting as they could result in 
lower data acquisition times. 
As discussed in Section 3.2.2, a 30 µs ICCD gate width is required for fluorescence 
spectral acquisitions due to the temporal jitter in the emitted laser pulses. While this gate 
delay was not an issue in the present work, if data acquisition requires reduction of the 
gate width size due to fast changes in the background lights (say inside an endoscope 
during in vivo data acquisition) then this issue would need to be addressed. In principle, 
an optical trigger from the photodiode in Figure 3.2 could be used for the ICCD instead 
of the electrical trigger from the T/C board. However, the gate delay can be set to only 85 
ns or higher employing the present Delay Generator, while the approximate time between 
the optical trigger and the time taken for the fluorescence to travel from the specimen via 
the optics and the fiber probe to the ICCD camera was found to be only ~ 20 ns. Thus, 
the fluorescence pulse will always be missed even when the gate delay is set to the 
minimum (as it would actually be 85 ns). A possible solution would be the use of longer 
fiber probes. This would artificially introduce a delay between the emitted laser pulse and 
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the time taken for the fluorescence to travel from the specimen via the optics and the fiber 
probe to the ICCD camera. For example, a 20 m long silica fiber would introduce an 
approximately 100 ns delay in light propagating through it thus, allowing the electronics 
to catch up. 
Newer, more sensitive detectors including the WTM (wavelength – time matrix) 
technology from Fluorescence Innovations Inc. (Bozeman, Montana) can be incorporated 
into the RFLS for fluorescence detection. The WTM technology would enable the rapid 
acquisition of spectrally resolved time-resolved data, thus allowing a more thorough 
optical investigation of biological systems. 
The ICCD camera is run in external trigger mode to synchronize the data acquisition with 
emitted laser pulses during fluorescence acquisitions (Section 3.2.2). For reflectance 
spectra acquisitions, this is not necessary and the ICCD can be run in an internal trigger 
mode. In the present ICCD camera, a switch between external and internal trigger modes 
has to be done manually. As a result, for reflectance measurements as well, the external 
trigger mode is being used in the interest of time and leads to the need for longer 
integration times. A quick switch to the internal trigger mode remotely using LabVIEW 
would lead to shorter integration times for reflectance data acquisition. Thus, an ICCD 
where one can change between external and internal trigger modes remotely could reduce 
reflectance acquisition times.  
The Biomedical Engineering Unit affiliated with the Institutional Review Board at the 
University of Michigan has recommended the use of an enclosed cart with larger wheels 
(for ease during transport) for housing the RFLS in a clinical setting. 
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7.2.2 Detection of pancreatic adenocarcinoma 
Further analysis of acquired optical spectroscopy data 
This dissertation work employed linear discriminant analysis and principal component 
analysis for tissue classification algorithm development. Other chemometric approaches 
can also be investigated to see if further improved classification can be achieved. Some 
of these techniques include multiple linear regression analysis, neural network analysis, 
logistic discrimination, partial least squares, multivariate linear regression, and support 
vector machine [4, 7, 19-23]. 
We are presently working on the analysis of additional multi-modal optical spectroscopy 
data measured ex vivo from human pancreatic cancer tissues during the course of this 
dissertation work. This includes data measured from 66 sites on 10 additional patients. 
The developed tissue classification algorithms will be tested on the larger data set of 
optical spectroscopy data. 
Another future work would be the classification of the optical data measured from sites 
that were excluded due to their histopathology in Section 4.2.1. These include serous 
cystadenomas, metastatic breast adenocarcinoma, intraductal papillary mucinous 
neoplasm, pancreatic intraepithelial neoplasia (a precursor to adenocarcinoma), scar or fat 
tissue, or a hybrid tissue site having two or more pathologies. 
In vivo optical measurements from human pancreatic tissues 
We are now poised for conducting in vivo optical studies, pending IRB approval. The 
first  in vivo  experiments would be undertaken during pancreatic surgery by employing a 
sterilized fiber optic probe with the same dimensions and design as the probe used in the  
ex vivo  studies. Apart from ensuring the manufacturing of a sterilizable fiber probe by a 
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vendor employing current good manufacturing practices defined by the Food and Drug 
Administration (FDA), the following two precautions must be taken to comply with the 
IRB requirements for this study: (i) a short-pass filter that cuts- off around 750-800 nm 
should be employed in front of the reflectance lamp source. This precaution is necessary 
to prevent any possible heating of the tissue due to light emitted in the NIR and IR region 
by the lamp. (ii) The laser and lamp lights should be blocked prior to data acquisition and 
should be opened only during acquisition of fluorescence and reflectance data from the 
tissues to minimize the amount of source light incident on the tissues.  
The eventual aim of the pancreas project would be to employ fiber probes that can fit 
through the EUS needle to obtain multi-modal optical spectroscopy data in vivo during 
EUS-FNA studies. The EUS needle (Echo-Tip 19, G31520, Wilson Cook Medical, 
Winston-Salem, NC) is 19 gauge and has an inner diameter of ~680 m (outer diameter 
of ~ 1.07 mm). The size of the fibers employed in the optical probe would have to be 
reduced to fit through the needle. Monte Carlo simulations could be undertaken to design 
the optimum fiber probe configuration which would provide the desired collection 
sensitivity and specificity to extract relevant structural and biochemical information from 
pancreatic tissues measurements during EUS-FNA procedures. 
Measurements of mouse models for pancreatic cancer 
Controlled experimentation and larger data sets can be achieved by studying animal 
models. In this dissertation work, human pancreatic xenografts were studied in mice with 
immunodeficiency. As a result, the mouse models did not mimic the increased fibrosis 
associated with adenocarcinoma in humans. Future studies could involve the 
measurement of mice models that more closely mimic progression of the disease in 
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humans, such as the models being developed in Prof. M. Pasca di Magliano’s laboratory 
at the University of Michigan. 
Tissue optical properties of pancreatic tissue 
The tissue optical properties of pancreatic tissue are needed for MC simulations. An 
experiment could be designed for extracting these properties for adenocarcinoma, 
pancreatitis, and normal pancreatic tissues by employing Integrating Sphere 
measurements (as described in Section 6.1.4). 
7.2.3 Assessment of articular cartilage constructs 
In this study, a large variation was seen in the extracted η values (ratio of the absorption 
coefficients of constituent fluorophores) for different samples. By repeating the study for 
a larger number of samples, the expected range of η values for naturally occurring AC 
tissues could be extracted. Thus, future work could include undertaking the above study 
for a larger set of porcine AC tissue to extract η values in the same manner as in the 
preliminary study reported here.  
The developed methods could then be applied to extract η values of tissue engineered AC 
constructs and a comparison could be made of η values for artificially constructed AC 
tissue with the range of η values for naturally occurring AC tissues. This could serve as a 
check of the viability of the construct. In addition, this method of extracting η values 
could be used to monitor the development of an AC tissue construct over time, in a non-
invasive manner. 
The approach presented here attributes a single fluorescence decay time to each 
constituent fluorophore in a tissue. A further refinement to this approach could include 
changes in fluorophore lifetime with emission wavelength. Although future systematic 
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studies on pure substances should resolve conflicting reports existing in the literature 
regarding lifetime variations with wavelength (e.g., for collagen [88]), it remains 
problematic to use data acquired on pure substances to describe those molecules in 
complex environments, such as biological tissues.  An alternate and more biologically 
relevant approach would be to employ optical molecular imaging (via, e.g., fluorescence 
lifetime imaging microscopy [100]) to characterize spatially-resolved endogenous 
fluorophores in their tissue environment. 
7.2.4 Assessment of cellular viability in EVPOME constructs 
More detailed optical characterization of EVPOME 
In this study, an initial attempt was made to obtain the tissue and fluorophore optical 
properties of EVPOME constructs. Alloderm® should be characterized further by 
measuring tissue optical properties using an integrating sphere as described in Section 
6.1.4. In addition, the presence of other fluorophores like elastin in the matrix should also 
be considered.  
Angled fiber optic probes for selectively exciting and detecting cellular fluorescence  
A conclusion of the study on EVPOME constructs was the need for alternative solutions 
to decrease acellular contributions to detected fluorescence while maximizing 
fluorescence from the cellular layer in EVPOME.  Preliminary studies undertaken by us 
using Monte Carlo codes at varying angles between source and detector fibers have 
shown promise at improving selective cellular fluorescence excitation and detection [99]. 
Future work could involve measurements of EVPOME constructs employing fiber optic 
probes designed with optimal angles between source and detector fibers as dictated by the 
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MC simulations. One potential problem with this approach could be the manufacturing of 
such probes. The preliminary angled fiber MC simulations have indicated the need for > 
50o angles between source and detector fibers which could be a design issue. 
Confocal microscopy for selectively exciting and detecting cellular fluorescence 
Another possible solution could be employing confocal microscopy for selectively 
measuring fluorescence from the cellular layer. We conducted preliminary experiments in 
which measurements from EVPOME constructs were made employing the Zeiss 
LSM510 Confocal fluorescence images were measured from a healthy Day 11 EVPOME 
construct at 364 nm and 458 nm excitation, to selectively detect NADH and FAD related 
fluorescence emission from these cells, respectively. Figure 7.1a and Figure 7.1b show 
the combined NADH and FAD emission from a non-stressed (NS) EVPOME construct, 
where Figure 7.1b is a zoomed in version. The haze in the images could be attributed to 
scattering of light from keratin and collagen layers. Thus, by employing confocal 
microscopy we could detect signals from the cellular layer in EVPOME. 
Employing redox ratios for assessment of tissue viability 
Metabolic activity in living cells and tissues has been assessed via optical measurements 
of the redox ratio of NADH and FAD, two cellular metabolic co-factors involved in the 
oxidative phosphorylation pathway in mitochondria. In their reduced and oxidized states, 
NADH and FAD are endogenous cellular fluorophores, respectively [101-117]. This 
method has been applied successfully to measure metabolic changes in mesenchymal 
stem cells placed in stem cell-supporting or osteogenic medium and found to report on 
stem-cell differentiation, cell density, and cell contact [108].  
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Figure 7.1. Confocal microscopy image of the combined NADH and FAD emission from 
keratinocytes in a healthy non-stressed (a – zoomed out, b – zoomed in) and stressed (a – zoomed 
out, b – zoomed in) day 11 EVPOME construct 
 
A preliminary attempt was made to calculate redox ratios from the healthy (non-stressed) 
and “stressed” day 11 EVPOME constructs. The stressed constructs simulated non-viable 
EVPOME constructs and were stressed by increasing incubation temperature of the 
constructs from 370C to 430C with 5% CO2, for 24 hours. Figure 7.1c and Figure 7.1d are 
confocal images from a stressed EVPOME sample. The cells were found to be smaller in 
the stressed case compared to the healthy case. Redox ratio defined as signal from FAD 
at 450 nm excitation divided by signal from NADH at 355 nm excitation was calculated 
from the cellular regions of the acquired images. The redox ratio was found to increase 
from the non – stressed (0.58 ± 0.06) to the stressed (0.99 ± 0.1) EVPOME constructs by 





72 ± 29 %. Thus, redox ratio measurements could be a feasible tool to detect differences 
between healthy and non-viable EVPOME constructs. 
7.3  Potential applications 
The instrument developed in this dissertation work is a versatile research instrument that 
can be easily optimized for non-invasive optical assessment via reflectance and 
fluorescence spectroscopy of a variety of biological systems in a laboratory or clinical 
setting. Some of the aspects that can be changed include fiber probe design (size and 
source-detector fiber geometry), spectroscopy at select wavelengths by the application of 
long-pass, short-pass or band-pass filters, and use of different excitation wavelengths for 
fluorescence spectroscopy.  
The algorithms developed in this dissertation work for pancreatic tissue classification 
could also be generally applied to classifying optical data obtained from other biological 
tissues, be it to differentiate healthy vs. stressed tissue engineered constructs or to 
differentiate between healthy and diseased biological tissues in animal models or humans. 
The general approach developed in this thesis for optical characterization by combining 
experimental and computational approaches in tissue optical spectroscopy should be 
broadly applicable to quantitative, non-invasive molecular sensing applications in 
complex, three-dimensional biological tissues. 
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